<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" id="humu6601291" xml:lang="en" article-type="research-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Hum Mutat</journal-id><journal-id journal-id-type="iso-abbrev">Hum Mutat</journal-id><journal-id journal-id-type="pmc-domain-id">4659</journal-id><journal-id journal-id-type="pmc-domain">humu</journal-id><journal-id journal-id-type="publisher-id">HUMU</journal-id><journal-title-group><journal-title>Human Mutation</journal-title></journal-title-group><issn pub-type="ppub">1059-7794</issn><issn pub-type="epub">1098-1004</issn><publisher><publisher-name>Wiley</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12759264</article-id><article-id pub-id-type="pmcid-ver">PMC12759264.1</article-id><article-id pub-id-type="pmcaid">12759264</article-id><article-id pub-id-type="pmcaiid">12759264</article-id><article-id pub-id-type="pmid">41488399</article-id><article-id pub-id-type="doi">10.1155/humu/6601291</article-id><article-id pub-id-type="publisher-id">HUMU6601291</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="overline"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic Yield</article-title></title-group><contrib-group><contrib id="cr-0001" contrib-type="author"><name name-style="western"><surname>Bonamici</surname><given-names initials="L">Lia</given-names></name><xref rid="aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cr-0002" contrib-type="author"><name name-style="western"><surname>Artuso</surname><given-names initials="L">Lucia</given-names></name><xref rid="aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cr-0003" contrib-type="author"><name name-style="western"><surname>Marino</surname><given-names initials="M">Marco</given-names></name><xref rid="aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib><contrib id="cr-0004" contrib-type="author"><name name-style="western"><surname>Toss</surname><given-names initials="A">Angela</given-names></name><xref rid="aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cr-0005" contrib-type="author"><name name-style="western"><surname>Sidoti</surname><given-names initials="D">Diletta</given-names></name><xref rid="aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="cr-0006" contrib-type="author"><name name-style="western"><surname>Barbieri</surname><given-names initials="E">Elena</given-names></name><xref rid="aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cr-0007" contrib-type="author"><name name-style="western"><surname>Venturelli</surname><given-names initials="M">Marta</given-names></name><xref rid="aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cr-0008" contrib-type="author"><name name-style="western"><surname>Marchi</surname><given-names initials="I">Isabella</given-names></name><xref rid="aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cr-0009" contrib-type="author"><name name-style="western"><surname>Pescucci</surname><given-names initials="C">Chiara</given-names></name><xref rid="aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="cr-0010" contrib-type="author"><name name-style="western"><surname>Manfredini</surname><given-names initials="R">Rossella</given-names></name><xref rid="aff-0005" ref-type="aff">
<sup>5</sup>
</xref><xref rid="aff-0006" ref-type="aff">
<sup>6</sup>
</xref></contrib><contrib id="cr-0011" contrib-type="author"><name name-style="western"><surname>Papi</surname><given-names initials="L">Laura</given-names></name><xref rid="aff-0004" ref-type="aff">
<sup>4</sup>
</xref></contrib><contrib id="cr-0012" contrib-type="author"><name name-style="western"><surname>Dominici</surname><given-names initials="M">Massimo</given-names></name><xref rid="aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff-0003" ref-type="aff">
<sup>3</sup>
</xref></contrib><contrib id="cr-0013" contrib-type="author"><name name-style="western"><surname>Cortesi</surname><given-names initials="L">Laura</given-names></name><xref rid="aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff-0007" ref-type="aff">
<sup>7</sup>
</xref></contrib><contrib id="cr-0014" contrib-type="author" corresp="yes"><name name-style="western"><surname>Tenedini</surname><given-names initials="E">Elena</given-names></name><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0285-765X</contrib-id><xref rid="aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff-0002" ref-type="aff">
<sup>2</sup>
</xref><address><email>elena.tenedini@unimore.it</email></address></contrib><contrib id="cr-0015" contrib-type="author"><name name-style="western"><surname>Tagliafico</surname><given-names initials="E">Enrico</given-names></name><xref rid="aff-0001" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff-0002" ref-type="aff">
<sup>2</sup>
</xref></contrib></contrib-group><contrib-group><contrib id="cr-0016" contrib-type="editor"><name name-style="western"><surname>Macrae</surname><given-names initials="F">Finlay</given-names></name><address><email>finlay.macrae@mh.org.au</email></address></contrib></contrib-group><aff id="aff-0001">
<label>
<sup>1</sup>
</label>
<named-content content-type="organisation-division">Department of Medical and Surgical Sciences</named-content>, <institution>University of Modena and Reggio Emilia</institution>, <city>Modena</city>, <country>Italy</country>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://unimore.it" ext-link-type="uri">unimore.it</ext-link>
</aff><aff id="aff-0002">
<label>
<sup>2</sup>
</label>
<named-content content-type="organisation-division">Diagnostic Hematology and Clinical Genomics Unit</named-content>, <named-content content-type="organisation-division">Department of Laboratory Medicine and Pathology</named-content>, <institution>Modena University Hospital</institution>, <city>Modena</city>, <country>Italy</country>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://unimore.it" ext-link-type="uri">unimore.it</ext-link>
</aff><aff id="aff-0003">
<label>
<sup>3</sup>
</label>
<named-content content-type="organisation-division">Oncology Unit</named-content>, <named-content content-type="organisation-division">Department of Oncology and Hematology</named-content>, <institution>University Hospital of Modena</institution>, <city>Modena</city>, <country>Italy</country>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://policlinico.mo.it" ext-link-type="uri">policlinico.mo.it</ext-link>
</aff><aff id="aff-0004">
<label>
<sup>4</sup>
</label>
<named-content content-type="organisation-division">Department of Experimental and Clinical Biomedical Sciences &#8220;Mario Serio&#8221;</named-content>, <institution>University of Florence</institution>, <city>Florence</city>, <country>Italy</country>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://unifi.it" ext-link-type="uri">unifi.it</ext-link>
</aff><aff id="aff-0005">
<label>
<sup>5</sup>
</label>
<named-content content-type="organisation-division">Department of Biomedical</named-content>, <named-content content-type="organisation-division">Metabolic and Neural Sciences</named-content>, <institution>University of Modena and Reggio Emilia</institution>, <city>Modena</city>, <country>Italy</country>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://unimore.it" ext-link-type="uri">unimore.it</ext-link>
</aff><aff id="aff-0006">
<label>
<sup>6</sup>
</label>
<named-content content-type="organisation-division">Interdepartmental Centre for Stem Cells and Regenerative Medicine</named-content>, <institution>University of Modena and Reggio Emilia</institution>, <city>Modena</city>, <country>Italy</country>, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://unimore.it" ext-link-type="uri">unimore.it</ext-link>
</aff><aff id="aff-0007">
<label>
<sup>7</sup>
</label>
<named-content content-type="organisation-division">UOC Oncologia</named-content>, <named-content content-type="organisation-division">Azienda USL-IRCCS Reggio Emilia</named-content>, <city>Reggio Emilia</city>, <country>Italy</country>
</aff><pub-date pub-type="epub"><day>03</day><month>1</month><year>2026</year></pub-date><pub-date pub-type="collection"><year>2026</year></pub-date><volume>2026</volume><issue-id pub-id-type="pmc-issue-id">503686</issue-id><elocation-id>6601291</elocation-id><history><date date-type="rev-recd"><day>28</day><month>10</month><year>2025</year></date><date date-type="received"><day>13</day><month>5</month><year>2025</year></date><date date-type="accepted"><day>13</day><month>11</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>03</day><month>01</month><year>2026</year></date></event><event event-type="pmc-live"><date><day>04</day><month>01</month><year>2026</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2026-01-05 11:25:13.240"><day>05</day><month>01</month><year>2026</year></date></event></pub-history><permissions><copyright-statement content-type="article-copyright">Copyright &#169; 2026 Lia Bonamici et al. Human Mutation published by John Wiley &amp; Sons Ltd.</copyright-statement><copyright-year>2026</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an open access article under the terms of the <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="HUMU-2026-6601291.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="file:HUMU-2026-6601291.pdf"/><abstract><p>The extensive use of next&#8208;generation sequencing (NGS) multi&#8208;gene panels and advanced analysis algorithms have led to the identification of numerous genetic variants associated with breast, ovarian, and pancreatic cancer. Copynumber variations (CNVs), defined as deletions and duplications of specific DNA regions, account for up to 10% of pathogenic variants and can affect any of the cancer&#8208;predisposing genes. Despite this, CNVs&#8217; contribution beyond BRCA1 and BRCA2 remains underexplored. This observational study analyzed data from 2949 patients, primarily affected by breast or ovarian cancer, who underwent NGS testing with a 22&#8208;gene hereditary cancer panel between 2018 and 2023, with a focus on CNV results. In line with comparison studies, a total diagnostic yield of 14.8% was observed with pathogenic variants in BRCA1, BRCA2, CHEK2, ATM, and PALB2 accounting for most of positive findings. In contrast, CNVs were found in 1.4% of patients, displaying a peculiar distribution pattern. PALB2 exhibited the highest frequency of pathogenic CNVs (66.7%), representing 62.2% of all PALB2 pathogenic variants. Notably, 24 out of 28 PALB2 CNV carriers shared the deletion of Exon 11. Further investigations revealed identical breakpoints and common geographical origins, and moreover, the same haplotype for some of the families suggests a relatively recent founder effect. Simultaneous sequence and copy number analyses resulted in likely higher positive predictive value of the test and, more interestingly, disclosed an unforeseen single contribution of CNVs in PALB2 gene, confirming geography as a key factor in shaping human genetic variations.</p></abstract><funding-group><award-group id="funding-0001"><funding-source><institution-wrap><institution>NextGenerationEU</institution><institution-id institution-id-type="doi">10.13039/100031478</institution-id></institution-wrap></funding-source><award-id>M4C1</award-id><award-id>CUP E53D23012150001</award-id><award-id>M4C2</award-id><award-id>CUP E93C22001860006</award-id></award-group><award-group id="funding-0002"><funding-source><institution-wrap><institution>Ministero dell&#8217;Istruzione, dell&#8217;Universit&#224; e della Ricerca</institution><institution-id institution-id-type="doi">10.13039/501100003407</institution-id></institution-wrap></funding-source><award-id>CUP E53C23000170001</award-id></award-group></funding-group><counts><fig-count count="5"/><table-count count="1"/><ref-count count="53"/><page-count count="11"/><word-count count="6153"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>source-schema-version-number</meta-name><meta-value>2.0</meta-value></custom-meta><custom-meta><meta-name>cover-date</meta-name><meta-value>2026</meta-value></custom-meta><custom-meta><meta-name>details-of-publishers-convertor</meta-name><meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:6.6.6 mode:remove_FC converted:03.01.2026</meta-value></custom-meta></custom-meta-group></article-meta><notes><p content-type="self-citation">
<mixed-citation publication-type="journal" id="humu6601291-cit-2001"><string-name name-style="western"><surname>Bonamici</surname>, <given-names>Lia</given-names></string-name>, 
<string-name name-style="western"><surname>Artuso</surname>, <given-names>Lucia</given-names></string-name>, 
<string-name name-style="western"><surname>Marino</surname>, <given-names>Marco</given-names></string-name>, 
<string-name name-style="western"><surname>Toss</surname>, <given-names>Angela</given-names></string-name>, 
<string-name name-style="western"><surname>Sidoti</surname>, <given-names>Diletta</given-names></string-name>, 
<string-name name-style="western"><surname>Barbieri</surname>, <given-names>Elena</given-names></string-name>, 
<string-name name-style="western"><surname>Venturelli</surname>, <given-names>Marta</given-names></string-name>, 
<string-name name-style="western"><surname>Marchi</surname>, <given-names>Isabella</given-names></string-name>, 
<string-name name-style="western"><surname>Pescucci</surname>, <given-names>Chiara</given-names></string-name>, 
<string-name name-style="western"><surname>Manfredini</surname>, <given-names>Rossella</given-names></string-name>, 
<string-name name-style="western"><surname>Papi</surname>, <given-names>Laura</given-names></string-name>, 
<string-name name-style="western"><surname>Dominici</surname>, <given-names>Massimo</given-names></string-name>, 
<string-name name-style="western"><surname>Cortesi</surname>, <given-names>Laura</given-names></string-name>, 
<string-name name-style="western"><surname>Tenedini</surname>, <given-names>Elena</given-names></string-name>, 
<string-name name-style="western"><surname>Tagliafico</surname>, <given-names>Enrico</given-names></string-name>, 
<article-title>Characterization of Copy Number Variants in Hereditary Cancer Patients Through NGS Shows a Distinctive PALB2 Contribution to the Diagnostic Yield</article-title>, 
<source>Human Mutation</source>, <volume>2026</volume>, <elocation-id>6601291</elocation-id>, 11 pages, <year>2026</year>. 
<pub-id pub-id-type="doi">10.1155/humu/6601291</pub-id></mixed-citation>
</p><fn-group><fn id="note-0001"><p>
<bold>Academic Editor:</bold> Finlay Macrae</p></fn></fn-group></notes></front><body><sec id="sec-0001"><title>1. Introduction</title><p>The genetic risk assessment for breast, ovarian, and pancreatic cancer was primarily focused on testing <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> genes [<xref rid="bib-0001" ref-type="bibr">1</xref>, <xref rid="bib-0002" ref-type="bibr">2</xref>]. Next&#8208;generation sequencing (NGS) has represented a paradigm shift for genetic testing, enabling high&#8208;throughput analysis of multiple genes, reducing time and costs [<xref rid="bib-0003" ref-type="bibr">3</xref>]. This has renewed researcher&#8217;s interest and unveiled an ever&#8208;growing list of genes associated to different levels of cancer risk [<xref rid="bib-0004" ref-type="bibr">4</xref>&#8211;<xref rid="bib-0008" ref-type="bibr">8</xref>]. The latest clinical recommendations, as outlined in the National Comprehensive Cancer Network Clinical Practice Guideline in Oncology (NCCN Guidelines) [<xref rid="bib-0009" ref-type="bibr">9</xref>], suggest offering multigene test panels including high&#8208; and moderate&#8208;risk genes associated with hereditary neoplasms, to patients suggestive of genetic predisposition to cancer [<xref rid="bib-0010" ref-type="bibr">10</xref>, <xref rid="bib-0011" ref-type="bibr">11</xref>]. Despite these advancements, a considerable portion of DNA alterations that cause tumor predisposition remains unexplored [<xref rid="bib-0012" ref-type="bibr">12</xref>, <xref rid="bib-0013" ref-type="bibr">13</xref>]. Among these, copy number variations (CNVs) that represent a challenging class of structural DNA variants, such as deletions or amplifications, remains underreported [<xref rid="bib-0006" ref-type="bibr">6</xref>, <xref rid="bib-0014" ref-type="bibr">14</xref>, <xref rid="bib-0015" ref-type="bibr">15</xref>].</p><p>For many years, multiplex ligation&#8208;dependent probe amplification (MLPA) and chromosomal microarray analysis have been broadly used in clinics for CNV detection [<xref rid="bib-0016" ref-type="bibr">16</xref>]. Although these technologies are accurate, they considerably impact turnaround times and costs of the diagnostic routine [<xref rid="bib-0017" ref-type="bibr">17</xref>&#8211;<xref rid="bib-0020" ref-type="bibr">20</xref>]. More recently, algorithms with high&#8208;grade reliability and accuracy were developed to detect CNVs from NGS data [<xref rid="bib-0020" ref-type="bibr">20</xref>, <xref rid="bib-0021" ref-type="bibr">21</xref>]. NGS has therefore become a first&#8208;approach single test that streamlines the detection of genomic alterations across many genes, including both sequence variants (single nucleotide variants or indels), and CNVs [<xref rid="bib-0012" ref-type="bibr">12</xref>, <xref rid="bib-0016" ref-type="bibr">16</xref>, <xref rid="bib-0022" ref-type="bibr">22</xref>, <xref rid="bib-0023" ref-type="bibr">23</xref>]. This advance has expanded the diagnostic application of NGS and collection of data about CNVs [<xref rid="bib-0006" ref-type="bibr">6</xref>, <xref rid="bib-0022" ref-type="bibr">22</xref>]. Nevertheless, MLPA remains essential as a confirmatory method [<xref rid="bib-0012" ref-type="bibr">12</xref>], particularly for high complexity regions, which are still challenging for short&#8208;read alignment algorithms.</p><p>Previous studies in hereditary cancer settings have established that CNVs account for around 7&#8211;10% of all pathogenic variants (PVs) and are not limited to <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> but also occur in other high or moderate risk genes, like <italic toggle="yes">PALB2</italic>, <italic toggle="yes">ATM</italic>, <italic toggle="yes">CHEK2</italic>, and <italic toggle="yes">RAD51C</italic> [<xref rid="bib-0006" ref-type="bibr">6</xref>, <xref rid="bib-0012" ref-type="bibr">12</xref>, <xref rid="bib-0019" ref-type="bibr">19</xref>, <xref rid="bib-0024" ref-type="bibr">24</xref>, <xref rid="bib-0025" ref-type="bibr">25</xref>]. These results confirm the need to offer a broader, robust, and accurate CNV testing, since comprehensive analysis can optimize medical decisions for patients and their families [<xref rid="bib-0022" ref-type="bibr">22</xref>].</p><p>This monocentric study aimed to examine prevalence and characteristics of genetic alterations, with a particular focus on CNV results, in 2949 consecutive patients who underwent NGS testing with a multigene panel for hereditary cancer during a 6&#8208;year period, from 2018 to 2023.</p></sec><sec id="sec-0002"><title>2. Material and Methods</title><sec id="sec-0003"><title>2.1. Study Population</title><p>Data were collected from consecutive patients who underwent genetic testing for Hereditary Cancer risk assessment from January 2018 to December 2023 at single testing center (2949 total), with a service area including patients living in two provinces of Modena and Reggio Emilia, Italy. Personal or familial inclusion criteria were evaluated during pre&#8208;test genetic counseling, in accordance with the current guidelines of the Italian public healthcare system, as described before [<xref rid="bib-0026" ref-type="bibr">26</xref>, <xref rid="bib-0027" ref-type="bibr">27</xref>]. Medical history and demographic elements were acquired from clinical indications prompting the test. This retrospective observational monocentric study was conducted in accordance with the Good Clinical Practice guidelines of the International Council for Harmonization and the Declaration of Helsinki. The study was approved by the local Ethics Committee (number 32/2024/OSS&#8727;/AOUMO SIRER ID 7122).</p></sec><sec id="sec-0004"><title>2.2. Sample Collection and DNA Isolation</title><p>Genomic DNA isolation from peripheral blood (PB) samples was performed with either the DNA Midi Kit via the QIASymphony platform (QIAGEN, Hilden, Germany) or the Maxwell 16 LEV Blood DNA Purification Kit (Promega, Madison, Wisconsin, United States), according to the manufacturers&#8217; instructions. Fluorometric quantification of nucleic acids was carried out with a Qubit dsDNA High Sensitivity kit (Thermo Scientific, Waltham, Massachusetts, United States).</p></sec><sec id="sec-0005"><title>2.3. NGS Panel</title><p>The entire study population was tested using the CE&#8208;IVD NGS&#8208;based multigene panel Hereditary Cancer Solution (HCS) v1.1, by SOPHiA GENETICS (Sophia Genetics, Lausanne, Switzerland). The hybridization capture&#8208;based library preparation was carried out as previously described [<xref rid="bib-0028" ref-type="bibr">28</xref>]. The design allows for the enrichment of coding and splicing regions of genes associated with hereditary cancer (<italic toggle="yes">APC</italic>, <italic toggle="yes">ATM</italic>, <italic toggle="yes">BARD1</italic>, <italic toggle="yes">BRCA1</italic>, <italic toggle="yes">BRCA2</italic>, <italic toggle="yes">BRIP1</italic>, <italic toggle="yes">CDH1</italic>, <italic toggle="yes">CHEK2</italic>, <italic toggle="yes">EPCAM</italic>, <italic toggle="yes">FAM175A</italic>, <italic toggle="yes">MLH1</italic>, <italic toggle="yes">MRE11A</italic>, <italic toggle="yes">MSH2</italic>, <italic toggle="yes">MSH6</italic>, <italic toggle="yes">MUTYH</italic>, <italic toggle="yes">NBN</italic>, <italic toggle="yes">PALB2</italic>, <italic toggle="yes">PIK3CA</italic>, <italic toggle="yes">PMS2</italic>, <italic toggle="yes">PTEN</italic>, <italic toggle="yes">RAD50</italic>, <italic toggle="yes">RAD51C</italic>, <italic toggle="yes">RAD51D</italic>, <italic toggle="yes">STK11</italic>, <italic toggle="yes">TP53</italic>, <italic toggle="yes">XRCC2</italic>) along with the pseudogene <italic toggle="yes">PMS2CL</italic>. The samples were sequenced in a 24 samples per run format, with a MiSeq Reagent Kit v3 (2&#215; 300&#8201;bp paired&#8208;end reads), on the Illumina MiSeq DX platform (Illumina, San Diego, California, United States), following the Illumina and SOPHiA GENETICS indications. A minimum coverage of 200&#215; was achieved in all the target regions.</p></sec><sec id="sec-0006"><title>2.4. Data Analysis and Interpretation of Genetic Variants</title><p>The sequencing data were processed simultaneously with two separate algorithms, using the CE&#8208;IVD SOPHiA Data Driven Medicine (DDM): platform for detecting both sequence variants (single nucleotide variants and indels) and copy number variations (CNVs). CNVs were detected using a proprietary algorithm based on coverage calculation of targeted regions, after applying double normalization within samples of the same run (both sample&#8208;specific and region specific), to avoid bias. In this study, we refer to CNVs as duplications or deletions affecting one or more exons of a gene.</p><p>Data analysis and interpretation were limited to a virtual panel of 22 actionable genes (<italic toggle="yes">APC</italic>, <italic toggle="yes">ATM</italic>, <italic toggle="yes">BARD1</italic>, <italic toggle="yes">BRCA1</italic>, <italic toggle="yes">BRCA2</italic>, <italic toggle="yes">BRIP1</italic>, <italic toggle="yes">CDH1</italic>, <italic toggle="yes">CHEK2</italic>, <italic toggle="yes">EPCAM</italic>, <italic toggle="yes">MLH1, MSH2</italic>, <italic toggle="yes">MSH6</italic>, <italic toggle="yes">MUTYH</italic>, <italic toggle="yes">NBN</italic>, <italic toggle="yes">PALB2</italic>, <italic toggle="yes">PMS2</italic>, <italic toggle="yes">PTEN</italic>, <italic toggle="yes">RAD50</italic>, <italic toggle="yes">RAD51C</italic>, <italic toggle="yes">RAD51D</italic>, <italic toggle="yes">STK11</italic>, <italic toggle="yes">TP53</italic>), according to the patients&#8217; informed consent. For the variant annotation process, the output from SOPHiA DDM was enriched with data from the literature, public databases (ClinVar [<xref rid="bib-0029" ref-type="bibr">29</xref>] and LOVD [<xref rid="bib-0030" ref-type="bibr">30</xref>]) and additional open&#8208;sources bioinformatics tools such as Varsome [<xref rid="bib-0031" ref-type="bibr">31</xref>], Annovar [<xref rid="bib-0032" ref-type="bibr">32</xref>], Franklin by Geenox (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://franklin.genoox.com" ext-link-type="uri">https://franklin.genoox.com</ext-link>), and Variant Effect Predictor [<xref rid="bib-0033" ref-type="bibr">33</xref>] (VEP).</p><p>Sequence variants were reported using the standard international HGVS (Human Genome Variation Society) nomenclature and classified according to the American College of Medical Genetics and Genomics (ACMG) [<xref rid="bib-0034" ref-type="bibr">34</xref>] in five classes (C1&#8208;C5): C5, pathogenic (P), C4, likely pathogenic (LP), C3, variant of uncertain significance (VUS), C2, likely benign (LB), and C1, benign (B). CNVs were evaluated according to ACMG and ClinGen standards [<xref rid="bib-0035" ref-type="bibr">35</xref>] with the CNV classification calculator (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="http://cnvcalc.clinicalgenome.org/cnvcalc/" ext-link-type="uri">http://cnvcalc.clinicalgenome.org/cnvcalc/</ext-link>).</p></sec><sec id="sec-0007"><title>2.5. Variants Confirmation</title><p>The sequence variants classified as pathogenic or likely pathogenic (LP/P) were confirmed by Sanger sequencing as already described [<xref rid="bib-0026" ref-type="bibr">26</xref>]. Sequencing data were analyzed with SeqScapeSoftware3.0 (Thermo Fisher Scientific, Waltham, Massachusetts, United States). For all the CNVs, orthogonal confirmatory tests were performed with the multiplex ligation&#8208;dependent probe amplification (MLPA) (MRC&#8208;Holland, Amsterdam, The Netherlands) technology and according with the manufacturer&#8217;s protocols. Results were analyzed with the Coffalyser. Net software (MRC&#8208;Holland) updated to the latest available version at the time of testing.</p></sec><sec id="sec-0008"><title>2.6. <italic toggle="yes">PALB2</italic> Breakpoints Characterization</title><p>To characterize the genomic breakpoint in <italic toggle="yes">PALB2</italic> exon 11 deletion heterozygotes, long&#8208;range PCR was performed using Platinum Taq DNA polymerase High Fidelity (Thermo Fisher Scientific) to generate a 13975&#8201;bp amplicon, spanning from the start of exon 10 to the end of exon 12 [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="NC_000016.9">NC_000016.9</ext-link>:g.23619120_23633094 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="NC_000016.10">NC_000016.10</ext-link>:g.23607800_23621774 on GRCh38]. The following commercially available M13&#8208;tailed primers were used: Hs00439505_CE, Hs00733432_CE (Thermo Fisher Scientific). Each 50&#8201;<italic toggle="yes">&#956;</italic>L reaction contained 300&#8201;ng of template DNA. The amplification conditions were as follows: 94&#176;C for 30&#8201;s, followed by 35 cycles at 94&#176;C for 15&#8201;s, 64&#176;C for 30&#8201;s, and 68&#176;C for 15&#8201;min. The PCR products were analyzed using the Agilent 4200 TapeStation system (Agilent Technologies, Santa Clara, California, United States) with Genomic DNA ScreenTape assay, to confirm the amplification products.</p><p>PCR products were subjected to Sanger sequencing with multiple custom primers designed with the Invitrogen OligoPerfect Designer (Thermo Fisher Scientific) to cover the flanking regions of AluSz, AluSp, AluYa5, AluSx, AluY elements in introns 10 and 11. RepeatMasker software (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.repeatmasker.org/cgi-bin/WEBRepeatMasker" ext-link-type="uri">https://www.repeatmasker.org/cgi-bin/WEBRepeatMasker</ext-link>) was used to identify genomic positions of repeated Alu elements within the <italic toggle="yes">PALB2</italic> sequence. The genomic breakpoint was identified using the following reverse primer:</p><p>ALU_SZ_R4: 5&#8242;&#8208;CATCAGTGTTTGTCAGAGGAACC&#8208;3&#8242;. Sequencing reaction was performed using BigDye Terminator v3.1. Capillary electrophoresis was performed on the 3500xL Dx Genetic Analyzer (Thermo Fisher Scientific). The collected data were analyzed and verified with SeqScape software v3.0 (Thermo Fisher Scientific).</p><p>Assessment of the PALB2 exon 11 tandem duplication was performed using PCR primers and experimental conditions as described by Bouras et al. [<xref rid="bib-0036" ref-type="bibr">36</xref>].</p></sec><sec id="sec-0009"><title>2.7. Microsatellite Analysis and Haplotyping</title><p>Microsatellite markers flanking the <italic toggle="yes">PALB2</italic> locus on chromosome 16 were genotyped using six polymorphic short tandem repeat (STR) loci: D16S3075, D16S3103, D16S3046, D16S3068, D16S3136, and D16S415. These markers were obtained from the ABI PRISM Linkage Mapping Set v2.5 (Applied Biosystems, Thermo Fisher Scientific). PCR amplification was performed according to the manufacturer&#8217;s protocol, and the resulting amplicons were resolved by capillary electrophoresis on a SeqStudio Genetic Analyzer (Applied Biosystems, Thermo Fisher Scientific). Fragment analysis was conducted using GeneMapper Software v6.0 (Applied Biosystems, Thermo Fisher Scientific), enabling precise allele sizing and genotyping.</p><p>A total of 35 individuals from 11 informative families, both carriers and non&#8208;carriers of the <italic toggle="yes">PALB</italic>2 exon 11 deletion, were genotyped. Haplotype reconstruction was performed manually based on the microsatellite genotyping data, assuming the minimum number of recombination events required to explain the observed allele segregation.</p></sec><sec id="sec-0010"><title>2.8. Statistical Analysis</title><p>Categorical variables were reported as absolute and percentage frequencies. Data were analyzed using Fisher&#8217;s exact test to identify associations between categorical variables. All analysis were performed with R software version 4.4.0 (R Core Team 2024, <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.r-project.org" ext-link-type="uri">https://www.R-project.org</ext-link>). Adjusted <italic toggle="yes">p</italic> values &lt;&#8201;0.05 were considered statistically significant.</p></sec></sec><sec id="sec-0011"><title>3. Results</title><sec id="sec-0012"><title>3.1. Patient Details and Yield of Reported Variants</title><p>We collected genetic test results and clinical data from a consecutive series of 2949 patients, predominantly of European ancestry, referred to the laboratory for evaluation by a NGS panel for hereditary cancer, between January 2018 and December 2023. Written informed consent was obtained from all patients to undergo NGS testing for 22 genes (<italic toggle="yes">APC</italic>, <italic toggle="yes">ATM</italic>, <italic toggle="yes">BARD1</italic>, <italic toggle="yes">BRCA1</italic>, <italic toggle="yes">BRCA2</italic>, <italic toggle="yes">BRIP1</italic>, <italic toggle="yes">CDH1</italic>, <italic toggle="yes">CHEK2</italic>, <italic toggle="yes">EPCAM</italic>, <italic toggle="yes">MLH1, MSH2</italic>, <italic toggle="yes">MSH6</italic>, <italic toggle="yes">MUTYH</italic>, <italic toggle="yes">NBN</italic>, <italic toggle="yes">PALB2</italic>, <italic toggle="yes">PMS2</italic>, <italic toggle="yes">PTEN</italic>, <italic toggle="yes">RAD50</italic>, <italic toggle="yes">RAD51C</italic>, <italic toggle="yes">RAD51D</italic>, <italic toggle="yes">STK11</italic>, <italic toggle="yes">TP53</italic>). Personal and family histories of cancer were provided by the referring clinicians and the most part, 2887/2949 (97.9%), had a personal tumor history (see Table <xref rid="sec-0026" ref-type="sec">S1</xref>). Among the affected, 1503/2887individuals (52.1%) received a breast cancer diagnosis and 200 (6.9%) had breast cancer before the age of 40 and were defined as Early Onset Breast Cancer (EOBC). Five hundred fifteen out of 2887 cases (17.8%) were triple&#8208;negative breast cancers (TNBCs), 62 patients (2.1%) were male breast cancer (MBC), and 4 (0.1%) had MBC and prostate cancer. One hundred forty&#8208;four patients (5.0%) were diagnosed with ovarian cancer, while a minor part had BC and OC (1.4%) or either BC or OC and another neoplasia, 3.1% and 0.5%, respectively. Pancreatic cancer cases accounted for 226 (7.8%) patients, and 8 individuals (0.3%) had both pancreatic and prostatic cancers. The subgroup of other cancers encompassed patients with personal history of melanoma, sarcoma, renal carcinoma, gastric, colorectal, uterine, or thyroid cancer. A positive family history of neoplasia was reported in 2428/2949 patients (82.3%) (Table <xref rid="sec-0026" ref-type="sec">S1</xref>).</p><p>Sequence variants (SNVs and indels), and CNVs classified as VUS, likely pathogenic, and pathogenic were included in the patients&#8217; genetic reports. More than half of the tested individuals, 57.0% (1681/2949), were found to carry reportable variants. Of those, 1246 (42.2%) had VUS but 435 individuals were detected with one or more LP or P genetic variants, accounting for a whole positive diagnostic yield equal to 14.8% (Table <xref rid="sec-0026" ref-type="sec">S1</xref>). Not surprisingly, sequence variants were the vast majority, with 395/435 individuals (90.8%), and CNVs the minor part, with 42/435 individuals (9.7%). Only two patients with both SNVs and CNVs.</p></sec><sec id="sec-0013"><title>3.2. Comparison of Results With Literature Data</title><p>A comparison between results obtained in our study population and other patients&#8217; cohorts was performed searching the literature for papers with similar testing admission criteria, prevalence of affected subjects and sequenced genes.</p><p>In most cases patients of the selected six cohorts, had a European geographic ancestry and a personal history of breast cancer, as shown in Table <xref rid="sec-0026" ref-type="sec">S2</xref>. They were all tested for variants with a NGS approach, looking for sequence variants and large rearrangements with commercial or custom panels focused on tumor suppressor genes involved in DNA repair mechanisms. Indeed, a common core of 9 genes (<italic toggle="yes">ATM</italic>, <italic toggle="yes">BRCA1</italic>, <italic toggle="yes">BRCA2</italic>, <italic toggle="yes">PTEN</italic>, <italic toggle="yes">TP53</italic>, <italic toggle="yes">CDH1</italic>, <italic toggle="yes">PALB2</italic>, <italic toggle="yes">STK11</italic>, <italic toggle="yes">CHEK2</italic>) is recurrent in the employed multigene panels and more than 80% of all the patients were tested for these genes.</p><p>The whole positive yield spanned from 9.0% to 22.1%, setting our result (14.8%) in the middle of the range (Table <xref rid="sec-0026" ref-type="sec">S2</xref>). Otherwise, we classified variants as with undetermined clinical significance (VUS, ACMG class 3) in 1246/2949 individuals (42.2%), which represent the highest yield among the studies. As expected, <italic toggle="yes">BRCA1</italic> and <italic toggle="yes">BRCA2</italic> were the most frequently mutated genes across the cohorts, along with <italic toggle="yes">CHEK2</italic>, <italic toggle="yes">ATM</italic>, and <italic toggle="yes">PALB2</italic>. According to published results, variants in these five genes describe the majority of positive findings, representing in our cohort 299/435 (68.7%) of positive patients (Figure <xref rid="sec-0026" ref-type="sec">S1</xref>).</p></sec><sec id="sec-0014"><title>3.3. Comparison of Copy Number Variations Results With Published Available Data</title><p>Fifty&#8208;three individuals carried variations of copy number in at least one of the tested genes, accounting for 1.8% (53/2949) of the total analyzed cases. Deletions together with two in&#8208;tandem duplications were classified as likely pathogenic or pathogenic (LP/P), making a total of 42/435 (9.7%) positive patients (Table <xref rid="tbl-0001" ref-type="table">1</xref>). The full list of CNVs is reported in the Table <xref rid="sec-0026" ref-type="sec">S3</xref>.</p><table-wrap position="float" id="tbl-0001" content-type="Table" orientation="portrait"><label>Table 1</label><caption><p>Comparison of CNVs analysis results in our study population and recently published studies, with a focus on <italic toggle="yes">PALB2</italic> variants.</p></caption><table frame="hsides" rules="groups"><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><col span="1"/><thead><tr><th align="left" rowspan="1" colspan="1">
<bold>Dataset</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Total tested individuals</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Geographic origin</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Tested genes</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>LP-P CNVs/tested individuals</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>LP-P CNVs/total positive</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>TOTAL PALB2/total positive</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>PALB2 CNVs/LP-P CNVs</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>PALB2 CNVs/TOTAL PALB2</bold>
</th><th align="center" rowspan="1" colspan="1">
<bold>Genes with the highest yield of LP-P CNV variants</bold>
</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Modena 2023</td><td align="center" rowspan="1" colspan="1">2949</td><td align="center" rowspan="1" colspan="1">European ancestry</td><td align="center" rowspan="1" colspan="1">22</td><td align="center" rowspan="1" colspan="1">42/2949 (1.4%)</td><td align="center" rowspan="1" colspan="1">9.7%</td><td align="center" rowspan="1" colspan="1">10.3%</td><td align="center" rowspan="1" colspan="1">66.7%</td><td align="center" rowspan="1" colspan="1">62.2%</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>PALB2</p></list-item><list-item><p>BRCA1</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Susswein 2016 [<xref rid="bib-0004" ref-type="bibr">4</xref>]</td><td align="center" rowspan="1" colspan="1">10,030</td><td align="center" rowspan="1" colspan="1">80% Caucasian</td><td align="center" rowspan="1" colspan="1">6&#8211;29</td><td align="center" rowspan="1" colspan="1">66/10,030 (0.7%)</td><td align="center" rowspan="1" colspan="1">7.3%</td><td align="center" rowspan="1" colspan="1">6.3%</td><td align="center" rowspan="1" colspan="1">6.1%</td><td align="center" rowspan="1" colspan="1">7.0%</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>BRCA1</p></list-item><list-item><p>MSH2</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Tsaousis 2019 [<xref rid="bib-0019" ref-type="bibr">19</xref>]</td><td align="center" rowspan="1" colspan="1">1197</td><td align="center" rowspan="1" colspan="1">35.5% Greek, 30.4% Romanian, 43.7% Turkish</td><td align="center" rowspan="1" colspan="1">26&#8211;33</td><td align="center" rowspan="1" colspan="1">16/1197 (1.3%)</td><td align="center" rowspan="1" colspan="1">6.1%</td><td align="center" rowspan="1" colspan="1">7.6%</td><td align="center" rowspan="1" colspan="1">0%</td><td align="center" rowspan="1" colspan="1">0%</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>BRCA1</p></list-item><list-item><p>BRCA2</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Mancini DiNardo 2019 <xref rid="bib-0012" ref-type="bibr">12</xref>
</td><td align="center" rowspan="1" colspan="1">376,159</td><td align="center" rowspan="1" colspan="1">No information provided</td><td align="center" rowspan="1" colspan="1">28</td><td align="center" rowspan="1" colspan="1">2334/376,159 (0.6%)</td><td align="center" rowspan="1" colspan="1">7.2%</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">7.0%</td><td align="center" rowspan="1" colspan="1">9.6%</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>BRCA1</p></list-item><list-item><p>PMS2</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Lerner&#8208;Ellis 2021 [<xref rid="bib-0024" ref-type="bibr">24</xref>]</td><td align="center" rowspan="1" colspan="1">3251</td><td align="center" rowspan="1" colspan="1">Mixed ethnicity (largely of European descent)</td><td align="center" rowspan="1" colspan="1">4&#8211;27</td><td align="center" rowspan="1" colspan="1">15/3251 (0.5%)</td><td align="center" rowspan="1" colspan="1">5.1%</td><td align="center" rowspan="1" colspan="1">8.8%</td><td align="center" rowspan="1" colspan="1">6.7%</td><td align="center" rowspan="1" colspan="1">3.8%</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>BRCA1</p></list-item><list-item><p>BARD1</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Bhai 2021 [<xref rid="bib-0006" ref-type="bibr">6</xref>]</td><td align="center" rowspan="1" colspan="1">2870</td><td align="center" rowspan="1" colspan="1">63.7% of European ancestry</td><td align="center" rowspan="1" colspan="1">24&#8211;31</td><td align="center" rowspan="1" colspan="1">27/2870 (0.9%)</td><td align="center" rowspan="1" colspan="1">6.2%</td><td align="center" rowspan="1" colspan="1">5.8% [in BC/OC positive patients]</td><td align="center" rowspan="1" colspan="1">3.7%</td><td align="center" rowspan="1" colspan="1">6.2% [in BC/OC positive patients]</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>BRCA1</p></list-item><list-item><p>BRCA2</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Lepkes 2021 <xref rid="bib-0017" ref-type="bibr">17</xref>
</td><td align="center" rowspan="1" colspan="1">4208</td><td align="center" rowspan="1" colspan="1">No information provided</td><td align="center" rowspan="1" colspan="1">17</td><td align="center" rowspan="1" colspan="1">76/4208 (1.8%)</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">2.6%</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>BRCA1</p></list-item><list-item><p>CHEK2</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">&#214;fverholm 2023 [<xref rid="bib-0025" ref-type="bibr">25</xref>]</td><td align="center" rowspan="1" colspan="1">4622</td><td align="center" rowspan="1" colspan="1">Swedish population</td><td align="center" rowspan="1" colspan="1">13</td><td align="center" rowspan="1" colspan="1">75/4622 (1.6%)</td><td align="center" rowspan="1" colspan="1">9.8%</td><td align="center" rowspan="1" colspan="1">5.1%</td><td align="center" rowspan="1" colspan="1">0%</td><td align="center" rowspan="1" colspan="1">0%</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>BRCA1</p></list-item><list-item><p>CHEK2</p></list-item></list>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Agiannitopoulos 2023 [<xref rid="bib-0020" ref-type="bibr">20</xref>]</td><td align="center" rowspan="1" colspan="1">2163</td><td align="center" rowspan="1" colspan="1">No information provided</td><td align="center" rowspan="1" colspan="1">52</td><td align="center" rowspan="1" colspan="1">50/2163 (2.3%)</td><td align="center" rowspan="1" colspan="1">10.8%</td><td align="center" rowspan="1" colspan="1">NA</td><td align="center" rowspan="1" colspan="1">0%</td><td align="center" rowspan="1" colspan="1">0%</td><td align="center" rowspan="1" colspan="1">
<list list-type="simple"><list-item><p>BRCA1</p></list-item><list-item><p>CHEK2</p></list-item></list>
</td></tr></tbody></table></table-wrap><p>The prevalence of LP/P CNVs in all the analyzed individuals (1.4%), as well as the prevalence in the positive patients (9.7%), aligns with the highest rates reported in the comparison studies (Table <xref rid="tbl-0001" ref-type="table">1</xref>). However, the distribution of this kind of variations among the genes exhibits a distinctive pattern, as shown in Figure <xref rid="fig-0001" ref-type="fig">1</xref>. While structural variants in the other cohorts, primarily involve <italic toggle="yes">BRCA1,</italic> we identified a significantly higher number of pathogenic CNVs in the <italic toggle="yes">PALB2</italic> gene, accounting for 66.7% (28/42) of the total LP/P CNVs. Indeed, 62.2% (28/45) of total <italic toggle="yes">PALB2</italic> positive patients carry large deletions or duplications. This is in contrast with other cohorts, where CNVs in <italic toggle="yes">PALB2</italic> do not exceed 7% of all the copy number variations and typically represent only a small fraction (0&#8211;9.6%) of all deleterious variants found in this gene (see Table <xref rid="tbl-0001" ref-type="table">1</xref>).</p><fig position="float" fig-type="Figure" id="fig-0001" orientation="portrait"><label>Figure 1</label><caption><p>Distribution of copy number variations in the study population. The genes with at least one CNV are shown in the <italic toggle="yes">x</italic>&#8208;axis. This study identified 53 CNVs in 52 individuals. Each bar is composed by the sum of VUS and pathogenic variants. VUS are depicted in blue (<italic toggle="yes">n</italic> = 11). Pathogenic variants are depicted in red (<italic toggle="yes">n</italic> = 42). The total number of variants identified in each gene is illustrated on top.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-1" orientation="portrait" xlink:href="HUMU-2026-6601291-g005.jpg"/></fig></sec><sec id="sec-0015"><title>3.4. PALB2 Variants</title><p>In the entire cohort, 45 patients tested positive for pathogenic CNVs and SNVs in <italic toggle="yes">PALB2</italic>, accounting for 1.5% of all tested individuals. Moreover, 94 patients (3.1%) harbor a variant with yet undetermined significance (ACMG class 3).</p><p>SNVs along with the Indels (111 in total, ACMG class 3&#8211;5), are distributed across the entire length of the coding sequence, as illustrated in Figure <xref rid="fig-0002" ref-type="fig">2</xref>. A small fraction (17/111) was classified as pathogenic and impacts the portions of the gene coding for domains involved in interactions with DNA and other proteins (shown in Figure <xref rid="fig-0002" ref-type="fig">2</xref> and details summarized in Table <xref rid="sec-0026" ref-type="sec">S4</xref>). Of these variants, 9/17 occur in the largest exons 4 and 5, and most of them (14/17) disrupt the reading frame, resulting in a nonfunctional protein.</p><fig position="float" fig-type="Figure" id="fig-0002" orientation="portrait"><label>Figure 2</label><caption><p>Lollipop plot of <italic toggle="yes">PALB2</italic> sequence and copy number variations. The figure illustrates the <italic toggle="yes">PALB2</italic> coding sequence structure, composed by 1186 amino acids, with its main functional domains. CC&#8201;=&#8201;coiled&#8208;coil domain. DBD1, DBD2&#8201;=&#8201;DNA binding domains, <italic toggle="yes">BRCA1</italic> binding domain. ChAM&#8201;=&#8201;chromatin&#8208;association motif. MBD&#8201;=&#8201;MRG15&#8208;binding domain. NES&#8201;=&#8201;nuclear export signal. WD40&#8201;=&#8201;WD 40 domain, <italic toggle="yes">BRCA2</italic> and <italic toggle="yes">RAD51C</italic> binding domains. Each dot shows the number of SNVs or indels insisting in the same amino acids. On the top of each dot is reported the amino acid change caused by each variant. VUS are depicted in yellow, and pathogenic variants are depicted in red. The grey bars at the bottom of the figure illustrate CNVs across <italic toggle="yes">PALB2</italic> coding sequence. In round brackets is shown the number of CNVs identified. DEL&#8201;=&#8201;deletion, DUP&#8201;=&#8201;duplication.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-3" orientation="portrait" xlink:href="HUMU-2026-6601291-g004.jpg"/></fig><p>On the contrary, CNVs do not span the entire coding sequence, but cluster (26 out of 28 patients) from exon 8 up to 13 that code for the WD40 domain of the protein. Even more interestingly, 24/2949 patients harbor the deletion of exon 11 (Figure <xref rid="fig-0002" ref-type="fig">2</xref> and Table <xref rid="sec-0026" ref-type="sec">S4</xref>). They are consecutive index cases belonging to different families and none of them had other concomitant clinically relevant variants, except one with a likely pathogenic SNV in <italic toggle="yes">BRIP1</italic> (data not shown).</p><p>Nineteen out of 24 patients were diagnosed with breast cancer, including seven with a triple negative phenotype and 3 with bilateral breast cancer, while 5 were diagnosed with pancreatic cancer, as listed in Table <xref rid="sec-0026" ref-type="sec">S4</xref>. All the patients reported a positive family history of cancer.</p><p>A total of 63 family members were tested for the deletion, and 23 were confirmed as positive heterozygotes (data not shown).</p><p>Breakpoints were characterized in carriers by amplification of genomic region encompassing <italic toggle="yes">PALB2</italic> region from exon 10 to exon 12. Sanger sequencing revealed that all the patients share the same 8204 base&#8208;pairs (bp) deletion [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="NC_000016.9">NC_000016.9</ext-link>:g.23622528_23630732del, (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="NC_000016.10">NC_000016.10</ext-link>:g.23611207_23619411del on GRCh38)], with the 5&#8217; and 3&#8217; breakpoints located within AluSx on intron 10 and AluSx1 in intron 11, respectively. Further comparison with already reported CNVs, as shown in Figure <xref rid="fig-0003" ref-type="fig">3</xref>, allowed us to refine the characterization of the cases previously described by Sidoti et al. [<xref rid="bib-0037" ref-type="bibr">37</xref>] revealing identical breakpoints with those identified in the current study. Details and coordinates are provided in Table <xref rid="sec-0026" ref-type="sec">S5</xref>.</p><fig-group position="float" id="fig-0003" content-type="Figure" orientation="portrait"><label>Figure 3</label><caption><p>Characterization of PALB2 exon 11 deletion breakpoints. (a) Schematic representation of the long&#8208;range PCR product spanning exon 10 to exon 12, sequenced to identify the deletion breakpoint: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="NC_000016.9">NC_000016.9</ext-link>:g.23622528_23630732del (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="pmc:entrez-nucleotide" xlink:href="NC_000016.10">NC_000016.10</ext-link>:g.23611207_23619411del on GRCh38). The characterized 8204&#8208;bp deletion, indicated in red, is shown in relation to a previously identified exon 11 duplication (also indicated in red) and other deletions or duplications described in the literature. AluSx in intron 10 and AluSx1 in intron 11 are the nearest Alu repeat elements to the deletion breakpoint. (b) Electropherogram showing the breakpoint sequence obtained with the ALU_SZ_R4 reverse primer. In the negative control sample, intron 10 is sequenced without interruptions.</p></caption><fig position="anchor" fig-type="Figure" id="figpt-0001" orientation="portrait"><caption><p>(a)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-5" orientation="portrait" xlink:href="HUMU-2026-6601291-g003.jpg"/></fig><fig position="anchor" fig-type="Figure" id="figpt-0002" orientation="portrait"><caption><p>(b)</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-7" orientation="portrait" xlink:href="HUMU-2026-6601291-g002.jpg"/></fig></fig-group><p>The geographic distribution of patients&#8217; birthplaces was analyzed to investigate whether a founder effect might account for the high prevalence of this exon 11 deletion. Notably, all the 24 patients belong to local families and were born in a specific area within the provinces of Modena and Reggio Emilia: a narrow flat region that borders to the south by the Apennine Mountain range and to the north by the Po River (Figure <xref rid="sec-0026" ref-type="sec">S2</xref>). No patients from the hilly or mountainous area of the Apennines, nor any born extra region or extra nation were found to be carriers of the Exon 11 deletion.</p><p>To further investigate the possibility of a common ancestor, haplotype analysis was performed. Eleven families out of the 24 carrying the deletion of <italic toggle="yes">PALB2</italic> exon 11 were investigated using polymorphic markers spanning the <italic toggle="yes">PALB2</italic> locus. Genotyping was conducted on probands and additional family members, with two to four individuals analyzed per family. One main haplotype was associated with the deletion and shared by six families (F3, F7, F9, F10, F16, F19), as shown in Figure <xref rid="fig-0004" ref-type="fig">4</xref>. One family (F2) shared the distal portion of the haplotype, most likely due to a recombination event between <italic toggle="yes">PALB2</italic> and D16S3046, whereas the remaining two families exhibited private haplotypes (Figure <xref rid="fig-0004" ref-type="fig">4</xref>). Importantly, the haplotypes associated with the deletion were absent in non&#8208;carrier relatives.</p><fig position="float" fig-type="Figure" id="fig-0004" orientation="portrait"><label>Figure 4</label><caption><p>Haplotype branching tree from 8 families and single haplotypes from 3 families segregating the deletion of PALB2 exon 11. The most common haplotype is indicated in <italic toggle="yes">bold</italic> numbers. The markers used are shown together with their position in the Marshfield genetic map and in the hg19 genome map. Family haplotypes are indicated with the corresponding family number (in <italic toggle="yes">bold</italic> and <italic toggle="yes">italics</italic>).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" id="jats-graphic-9" orientation="portrait" xlink:href="HUMU-2026-6601291-g001.jpg"/></fig></sec></sec><sec id="sec-0016"><title>4. Discussion</title><p>Copy number variations (CNVs) are known contributors to hereditary cancer, accounting for a small but significant fraction of patients [<xref rid="bib-0006" ref-type="bibr">6</xref>, <xref rid="bib-0012" ref-type="bibr">12</xref>]. In this study, we described the results of a single&#8208;center cohort of patients tested for 22 genes, analyzed simultaneously for sequence and CNVs. The variability observed when comparing our cohort to others can be reasonably explained in selection criteria for genetic testing, the proportion of affected versus unaffected individuals, the distribution of cancer types, and the total number of tested patients. Despite these differences, the overall diagnostic yield of 14.8% observed in our study remains consistent with the reported range of 10&#8211;20% for germline variants associated with hereditary cancer [<xref rid="bib-0006" ref-type="bibr">6</xref>, <xref rid="bib-0007" ref-type="bibr">7</xref>, <xref rid="bib-0038" ref-type="bibr">38</xref>, <xref rid="bib-0039" ref-type="bibr">39</xref>]. Likewise, clinically relevant sequence variants were identified in all genes, except for <italic toggle="yes">STK11,</italic> and the most frequently mutated genes (<italic toggle="yes">BRCA2, BRCA1, CHEK2, ATM</italic>, and <italic toggle="yes">PALB2</italic>) align with findings from comparison studies, accounting for 68.7% of total positive patients [<xref rid="bib-0004" ref-type="bibr">4</xref>, <xref rid="bib-0006" ref-type="bibr">6</xref>, <xref rid="bib-0013" ref-type="bibr">13</xref>, <xref rid="bib-0019" ref-type="bibr">19</xref>, <xref rid="bib-0024" ref-type="bibr">24</xref>, <xref rid="bib-0025" ref-type="bibr">25</xref>]. Only few patients are reported with deleterious sequence variants in one of the remaining tested genes, suggesting that each gene beyond this core set, has a minimal impact on the total diagnostic yield.</p><p>As far as large rearrangements are concerned, the observed overall percentage of pathogenic copy number variations (9.7% of positive patients), is consistent with the previously described 7&#8208;10% rate among positive individuals [<xref rid="bib-0006" ref-type="bibr">6</xref>, <xref rid="bib-0012" ref-type="bibr">12</xref>, <xref rid="bib-0019" ref-type="bibr">19</xref>], but its distribution among the tested genes differs significantly. Deleterious CNVs were found in just few genes (<italic toggle="yes">PALB2, BRCA1, BRIP1, ATM, PMS2, CHEK2, BARD1, BRCA2, CDH1, MLH1</italic>, and <italic toggle="yes">PTEN</italic>) and surprisingly more than half of deletions and duplications occurred in one single gene, the partner and localizer of <italic toggle="yes">BRCA2, PALB2</italic>. It encodes a protein that promotes stability and localization of Brca2 and stimulates Rad51 function [<xref rid="bib-0040" ref-type="bibr">40</xref>, <xref rid="bib-0041" ref-type="bibr">41</xref>], playing an essential role in the homologous recombination repairing of DNA. In recent years, <italic toggle="yes">PALB2</italic> has emerged as one of the most important cancers predisposing genes [<xref rid="bib-0042" ref-type="bibr">42</xref>], conferring an increased risk of breast [<xref rid="bib-0008" ref-type="bibr">8</xref>, <xref rid="bib-0043" ref-type="bibr">43</xref>&#8211;<xref rid="bib-0046" ref-type="bibr">46</xref>], pancreatic [<xref rid="bib-0047" ref-type="bibr">47</xref>], gastric and ovarian cancer [<xref rid="bib-0048" ref-type="bibr">48</xref>]. The growing number of clinical trials encompassing germline <italic toggle="yes">PALB2</italic> mutations as inclusion criteria [<xref rid="bib-0049" ref-type="bibr">49</xref>], highlights the increasing interest for this gene to improve patient clinical management. In contrast to studies describing <italic toggle="yes">PALB2</italic> deletions and duplications to be generally uncommon, reaching a maximum percentage of 7% of identified LP&#8208;P CNVs [<xref rid="bib-0004" ref-type="bibr">4</xref>, <xref rid="bib-0006" ref-type="bibr">6</xref>, <xref rid="bib-0012" ref-type="bibr">12</xref>, <xref rid="bib-0017" ref-type="bibr">17</xref>, <xref rid="bib-0019" ref-type="bibr">19</xref>, <xref rid="bib-0020" ref-type="bibr">20</xref>, <xref rid="bib-0024" ref-type="bibr">24</xref>, <xref rid="bib-0025" ref-type="bibr">25</xref>], our data show a percentage of 66.7%, which is much higher. The very high number of single&#8208;copy losses or gains identified in our cohort, affect the WD40 domain (26/28 patients), known to be crucial for interactions of Palb2 with DNA damage repair proteins [<xref rid="bib-0043" ref-type="bibr">43</xref>] and confirming the previous observation of Yang and colleagues that observed that exon deletions or duplications of this gene clustered in that domain [<xref rid="bib-0046" ref-type="bibr">46</xref>]. Moving forward, 24/28 patients (85.7%) share the same single&#8208;copy deletion of exon 11. No data are actually present in frequency databases and only very few cancer patients have been reported with this deletion [<xref rid="bib-0004" ref-type="bibr">4</xref>, <xref rid="bib-0037" ref-type="bibr">37</xref>, <xref rid="bib-0047" ref-type="bibr">47</xref>, <xref rid="bib-0050" ref-type="bibr">50</xref>&#8211;<xref rid="bib-0052" ref-type="bibr">52</xref>]. All the individuals with exon 11 deletion were affected at the time of testing: 19/24 (79.2%) with a personal diagnosis of breast cancer, including 7/19 (36.8%) TNBC cases, and 5/24 (20.8%) with pancreatic cancer. Interestingly, a high number of pancreatic cancers were observed in this subgroup compared to all the individual affected with no exon 11 deletion. Despite the modest size of our population a statistically relevant association (<italic toggle="yes">p</italic> = 0.04) was found, supporting the hypothesis that this variant may positively correlate with a higher risk of developing pancreatic cancer.</p><p>Schrader and colleagues [<xref rid="bib-0050" ref-type="bibr">50</xref>] tested positive for exon 11 deletion, an Ashkenazi Jewish female with a history of ovarian and breast cancer, but after the analysis of more than a thousand probands with familial breast, ovarian, or pancreatic cancer, they proved that this deletion variant does not appear to be a founder mutation in Ashkenazim [<xref rid="bib-0050" ref-type="bibr">50</xref>]. No other information about a common geographical or ethnic origin can be inferred from the very few carriers described in the rest of the literature [<xref rid="bib-0004" ref-type="bibr">4</xref>, <xref rid="bib-0047" ref-type="bibr">47</xref>, <xref rid="bib-0051" ref-type="bibr">51</xref>, <xref rid="bib-0052" ref-type="bibr">52</xref>], except for the cases recently reported by Sidoti and colleagues<sup>38</sup>in the near Tuscany region of Northern Italy. In this cohort, the deleted positive heterozygotes are apparently unrelated index cases; they share a common area of birth, namely provinces of Modena and Reggio Emilia, a plain territory divided from Tuscany by the Appennino mountains. They harbor a common 8204 base pairs deletion with identical breakpoints. Deletion size and boundaries are completely distinct from the single case described by Schrader [<xref rid="bib-0050" ref-type="bibr">50</xref>], while they turned to be indentical to the deletion described by Sidoti [<xref rid="bib-0037" ref-type="bibr">37</xref>]. The deletion breakpoints occur within Alu repeat elements AluSx/AluSx1, confirming that Alu mediated non&#8208;allelic homologous recombination is the most likely causative molecular mechanism [<xref rid="bib-0053" ref-type="bibr">53</xref>]. Haplotype analysis of the most informative families, 11 in total, was conducted to verify whether the exon 11 deletion of <italic toggle="yes">PALB2</italic> could be a recurrent event arose independently in multiple individuals and resulting in a similar phenotypic effect or be passed down through generations from a common ancestor. The analysis revealed that six families share a chromosomal segment of about eight centimorgans (cM) encompassing the variant, consistent with a relatively recent founder event. One family exhibited a partially common haplotype that may have resulted from a recombination event between <italic toggle="yes">PALB2</italic> and D16S3046. Two families share neither the haplotype associated with the rearrangement nor the haplotypes identified by Sidoti and collaborators. However, the distance between the microsatellite markers analyzed does not exclude the presence of a smaller shared haplotype among these families and possibly the ones identified in the adjacent region of Tuscany.</p><p>Expanding data collection to nearby centers and analyzing microsatellites in closer proximity to the <italic toggle="yes">PALB2</italic> gene may enhance our understanding of distribution of the <italic toggle="yes">PALB2</italic> exon 11 deletion in Italy and fine&#8208;map the haplotype, while international collaborations will be essential to fully elucidate the prevalence and clinical impact of this rare variant. In this context, joining efforts with initiatives such as the PALB2 Interest Group (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.palb2.org/team/palb2-interest-group/" ext-link-type="uri">https://www.palb2.org/team/palb2-interest-group/</ext-link>) could provide access to larger datasets and promote coordinated research efforts across populations.</p></sec><sec id="sec-0017"><title>5. Conclusions</title><p>The use of NGS&#8208;based multigene panels has expanded the number of genes routinely tested in diagnostics and, at the same time, has produced robust data suitable for simultaneous sequence and copy number analyses. In our cohort, the combination of these factors disclosed both expected and unexpected results: as expected, a higher positive predictive value for the test, but also an unforeseen unique contribution of a single CNV suggestive of a founder effect, to the diagnostic yield.</p><p>These results emphasize both the broad, global potential of NGS combined sequence and copy number analyses and the importance of understanding and addressing local variations and specificities.</p></sec><sec id="sec-0020"><title>Ethics Statement</title><p>Written informed consent was obtained from all of the patients that were educated about the significance and limitations of NGS diagnostics and the potential for incidental findings. All genetic analyses and investigations were performed in accordance with the guidelines of the Declaration of Helsinki, and this study was approved by local ethic committee (Area Vasta Emilia Nord Ethics Committee, number 32/2024/OSS&#8727;/AOUMO SIRER ID 7122).</p></sec><sec id="sec-0021"><title>Disclosure</title><p>All authors reviewed and approved the manuscript prior to submission.</p></sec><sec sec-type="COI-statement" id="sec-0022"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></sec><sec id="sec-0023"><title>Author Contributions</title><p>L.B., E.Te., E.Ta.: conceptualization. L.B., E.Te., D.S.: formal analysis. L.B., E.Te., L.A., M.M., D.S., C.P., L.P., I.M.: data curation. L.B., E.Te., L.A., M.M., I.M., A.T., E.B., M.V., L.C., D.S., C.P.: resources. L.B., E.Te., E.Ta., L.A., M.M., A.T., L.C.: writing original draft. E.Te., L.P., E.Ta., R.M., M.D., L.C.: writing review. Elena Tenedini and Enrico Tagliafico equally contributed to the work.</p></sec><sec id="sec-0024"><title>Funding</title><p>This research was funded by the NextGenerationEU, M4C1, CUP E53D23012150001 to Elena Tenedini and M4C2, CUP E93C22001860006 to Angela Toss, Rossella Manfredini, and Massimo Dominici, and the Italian Ministry of University and Research, CUP E53C23000170001 to Enrico Tagliafico.</p></sec><sec id="sec-0026"><title>Supporting Information</title><p>Additional supporting information can be found online in the Supporting Information section.</p></sec><sec sec-type="supplementary-material"><title>Supporting information</title><supplementary-material id="link-0001" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Supporting Information 1</bold> Figure S1: Distribution of SNVs/indels. (A) Pathogenic/likely pathogenic SNVs or indels. Four hundred sixteen P/LP variants were detected in 395 patients; variant counts per gene are shown above each bar, with unique variants in parentheses. (B) VUS alterations. One thousand nine hundred eighty&#8208;three VUS SNVs or indels were identified in 2949 individuals; variant counts per gene are shown.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HUMU-2026-6601291-s001.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="link-0002" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Supporting Information 2</bold> Figure S2: Geographic origin of <italic toggle="yes">PALB2</italic> exon 11 deletion carriers. The map displays the birthplaces of carriers, marked by red circles. The red dashed line indicates the Modena and Reggio Emilia provincial borders, main areas served by the laboratory. The Po River appears as a blue line above; the Apennine Mountains range below. Supporting Information 3 Source: Google Maps, edited by the author. Accessed on September 2, 2024.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HUMU-2026-6601291-s006.pdf" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="link-0003" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Supporting Information 3</bold> Table S1: Personal and family clinical details of the study population.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HUMU-2026-6601291-s005.xlsx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="link-0004" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Supporting Information 4</bold> Table S2: Comparison of variants analysis results in our study population and recently published studies.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HUMU-2026-6601291-s004.xlsx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="link-0005" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Supporting Information 5</bold> Table S3: CNVs full list.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HUMU-2026-6601291-s003.xlsx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="link-0006" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Supporting Information 6</bold> Table S4: <italic toggle="yes">PALB2</italic> pathogenic variant full list.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HUMU-2026-6601291-s002.xlsx" position="float" orientation="portrait"/></supplementary-material><supplementary-material id="link-0007" position="float" content-type="local-data" orientation="portrait"><caption><p>
<bold>Supporting Information 7</bold> Table S5: Details of <italic toggle="yes">PALB2</italic> exon 11 CNVs reported in the literature.</p></caption><media xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="HUMU-2026-6601291-s007.xlsx" position="float" orientation="portrait"/></supplementary-material></sec></body><back><ack id="sec-0025"><title>Acknowledgments</title><p>The authors thank the Angela Serra Association for Cancer Research for support to patients care and research activities and Miriam Fiori and Teresa Rauseo for effective organization, participation, and contribution to the study.</p></ack><sec sec-type="data-availability" id="sec-0019"><title>Data Availability Statement</title><p>Data supporting this study&#8217;s findings are available in the supplement materials. Full patients&#8217; data are not available publicly to respect of participant privacy and consent. Not shown data are available upon request to Dr. Elena Tenedini, <email>elena.tenedini@unimore.it</email>.</p></sec><ref-list><ref id="bib-0001"><label>1</label><mixed-citation publication-type="journal" id="cit-0001"><string-name name-style="western"><surname>Couch</surname><given-names>F. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Nathanson</surname><given-names>K. L.</given-names></string-name>, and 
<string-name name-style="western"><surname>Offit</surname><given-names>K.</given-names></string-name>, <article-title>Two Decades After <italic toggle="yes">BRCA:</italic> Setting Paradigms in Personalized Cancer Care and Prevention</article-title>, <source>Science</source>. (<year>2014</year>) <volume>343</volume>, no. 6178, <fpage>1466</fpage>&#8211;<lpage>1470</lpage>, <pub-id pub-id-type="doi">10.1126/science.1251827</pub-id>, 2-s2.0-84896995635, 24675953.<pub-id pub-id-type="pmid">24675953</pub-id><pub-id pub-id-type="pmcid">PMC4074902</pub-id></mixed-citation></ref><ref id="bib-0002"><label>2</label><mixed-citation publication-type="journal" id="cit-0002"><string-name name-style="western"><surname>Melchor</surname><given-names>L.</given-names></string-name> and 
<string-name name-style="western"><surname>Ben&#237;tez</surname><given-names>J.</given-names></string-name>, <article-title>The Complex Genetic Landscape of Familial Breast Cancer</article-title>, <source>Human Genetics</source>. (<year>2013</year>) <volume>132</volume>, no. 8, <fpage>845</fpage>&#8211;<lpage>863</lpage>, <pub-id pub-id-type="doi">10.1007/s00439-013-1299-y</pub-id>, 2-s2.0-84880922362, 23552954.<pub-id pub-id-type="pmid">23552954</pub-id></mixed-citation></ref><ref id="bib-0003"><label>3</label><mixed-citation publication-type="journal" id="cit-0003"><string-name name-style="western"><surname>Shah</surname><given-names>P. D.</given-names></string-name> and 
<string-name name-style="western"><surname>Nathanson</surname><given-names>K. L.</given-names></string-name>, <article-title>Application of Panel-Based Tests for Inherited Risk of Cancer</article-title>, <source>Annual Review of Genomics and Human Genetics</source>. (<year>2017</year>) <volume>18</volume>, no. 1, <fpage>201</fpage>&#8211;<lpage>227</lpage>, <pub-id pub-id-type="doi">10.1146/annurev-genom-091416-035305</pub-id>, 2-s2.0-85028771600, 28504904.<pub-id pub-id-type="pmid">28504904</pub-id></mixed-citation></ref><ref id="bib-0004"><label>4</label><mixed-citation publication-type="journal" id="cit-0004"><string-name name-style="western"><surname>Susswein</surname><given-names>L. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Marshall</surname><given-names>M. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Nusbaum</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Vogel Postula</surname><given-names>K. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Weissman</surname><given-names>S. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Yackowski</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Vaccari</surname><given-names>E. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Bissonnette</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Booker</surname><given-names>J. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Cremona</surname><given-names>M. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Gibellini</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Murphy</surname><given-names>P. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Pineda-Alvarez</surname><given-names>D. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Pollevick</surname><given-names>G. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Xu</surname><given-names>Z.</given-names></string-name>, 
<string-name name-style="western"><surname>Richard</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Bale</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Klein</surname><given-names>R. T.</given-names></string-name>, 
<string-name name-style="western"><surname>Hruska</surname><given-names>K. S.</given-names></string-name>, and 
<string-name name-style="western"><surname>Chung</surname><given-names>W. K.</given-names></string-name>, <article-title>Pathogenic and Likely Pathogenic Variant Prevalence Among the First 10,000 Patients Referred for Next-Generation Cancer Panel Testing</article-title>, <source>Genetics in Medicine</source>. (<year>2016</year>) <volume>18</volume>, no. 8, <fpage>823</fpage>&#8211;<lpage>832</lpage>, <pub-id pub-id-type="doi">10.1038/gim.2015.166</pub-id>, 2-s2.0-84981169037, 26681312.<pub-id pub-id-type="pmid">26681312</pub-id><pub-id pub-id-type="pmcid">PMC4985612</pub-id></mixed-citation></ref><ref id="bib-0005"><label>5</label><mixed-citation publication-type="journal" id="cit-0005"><string-name name-style="western"><surname>Lee</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Seifert</surname><given-names>B. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Shimelis</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Ghosh</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Crowley</surname><given-names>S. B.</given-names></string-name>, 
<string-name name-style="western"><surname>Carter</surname><given-names>N. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Doonanco</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Foreman</surname><given-names>A. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Ritter</surname><given-names>D. I.</given-names></string-name>, 
<string-name name-style="western"><surname>Jimenez</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Trapp</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Offit</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Plon</surname><given-names>S. E.</given-names></string-name>, and 
<string-name name-style="western"><surname>Couch</surname><given-names>F. J.</given-names></string-name>, <article-title>Clinical Validity Assessment of Genes Frequently Tested on Hereditary Breast and Ovarian Cancer Susceptibility Sequencing Panels</article-title>, <source>Genetics in Medicine</source>. (<year>2019</year>) <volume>21</volume>, no. 7, <fpage>1497</fpage>&#8211;<lpage>1506</lpage>, <pub-id pub-id-type="doi">10.1038/s41436-018-0361-5</pub-id>, 2-s2.0-85058057334, 30504931.<pub-id pub-id-type="pmid">30504931</pub-id><pub-id pub-id-type="pmcid">PMC6579711</pub-id></mixed-citation></ref><ref id="bib-0006"><label>6</label><mixed-citation publication-type="journal" id="cit-0006"><string-name name-style="western"><surname>Bhai</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Levy</surname><given-names>M. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Rooney</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Carere</surname><given-names>D. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Reilly</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Kerkhof</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Volodarsky</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Stuart</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Kadour</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Panabaker</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Schenkel</surname><given-names>L. C.</given-names></string-name>, 
<string-name name-style="western"><surname>Lin</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Ainsworth</surname><given-names>P.</given-names></string-name>, and 
<string-name name-style="western"><surname>Sadikovic</surname><given-names>B.</given-names></string-name>, <article-title>Analysis of Sequence and Copy Number Variants in Canadian Patient Cohort With Familial Cancer Syndromes Using a Unique Next Generation Sequencing Based Approach</article-title>, <source>Frontiers in Genetics</source>. (<year>2021</year>) <volume>12</volume>, <pub-id pub-id-type="doi">10.3389/fgene.2021.698595</pub-id>, 34326862.<pub-id pub-id-type="pmcid">PMC8314385</pub-id><pub-id pub-id-type="pmid">34326862</pub-id></mixed-citation></ref><ref id="bib-0007"><label>7</label><mixed-citation publication-type="journal" id="cit-0007"><string-name name-style="western"><surname>LaDuca</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Polley</surname><given-names>E. C.</given-names></string-name>, 
<string-name name-style="western"><surname>Yussuf</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Hoang</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Gutierrez</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Hart</surname><given-names>S. N.</given-names></string-name>, 
<string-name name-style="western"><surname>Yadav</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Hu</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Na</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Goldgar</surname><given-names>D. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Fulk</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Smith</surname><given-names>L. P.</given-names></string-name>, 
<string-name name-style="western"><surname>Horton</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Profato</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Pesaran</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Gau</surname><given-names>C.-L.</given-names></string-name>, 
<string-name name-style="western"><surname>Pronold</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Davis</surname><given-names>B. T.</given-names></string-name>, 
<string-name name-style="western"><surname>Chao</surname><given-names>E. C.</given-names></string-name>, 
<string-name name-style="western"><surname>Couch</surname><given-names>F. J.</given-names></string-name>, and 
<string-name name-style="western"><surname>Dolinsky</surname><given-names>J. S.</given-names></string-name>, <article-title>A Clinical Guide to Hereditary Cancer Panel Testing: Evaluation of Gene-Specific Cancer Associations and Sensitivity of Genetic Testing Criteria in a Cohort of 165, 000 High-Risk Patients</article-title>, <source>Genetics in Medicine</source>. (<year>2020</year>) <volume>22</volume>, no. 2, <fpage>407</fpage>&#8211;<lpage>415</lpage>, <pub-id pub-id-type="doi">10.1038/s41436-019-0633-8</pub-id>, 2-s2.0-85070823398, 31406321.<pub-id pub-id-type="pmid">31406321</pub-id><pub-id pub-id-type="pmcid">PMC7000322</pub-id></mixed-citation></ref><ref id="bib-0008"><label>8</label><mixed-citation publication-type="journal" id="cit-0008"><string-name name-style="western"><surname>Breast Cancer Association Consortium</surname></string-name>, <article-title>Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women</article-title>, <source>New England Journal of Medicine</source>. (<year>2021</year>) <volume>384</volume>, <fpage>428</fpage>&#8211;<lpage>439</lpage>, <pub-id pub-id-type="doi">10.1056/NEJMoa1913948</pub-id>.<pub-id pub-id-type="pmid">33471991</pub-id><pub-id pub-id-type="pmcid">PMC7611105</pub-id></mixed-citation></ref><ref id="bib-0009"><label>9</label><mixed-citation publication-type="miscellaneous" id="cit-0009"><article-title>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Guideline Version 3.2024 National Comprehensive Cancer Network, Inc</article-title>, <year>2024</year>, All rights reserved. Accessed [05/25, 2024], <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.nccn.org/guidelines/guidelines-detail?category=2%26id=1545" ext-link-type="uri">https://www.nccn.org/guidelines/guidelines-detail?category=2%26id=1545</ext-link>.</mixed-citation></ref><ref id="bib-0010"><label>10</label><mixed-citation publication-type="journal" id="cit-0010"><string-name name-style="western"><surname>Sessa</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Balma&#241;a</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Bober</surname><given-names>S. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Cardoso</surname><given-names>M. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Colombo</surname><given-names>N.</given-names></string-name>, 
<string-name name-style="western"><surname>Curigliano</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Domchek</surname><given-names>S. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Evans</surname><given-names>D. G.</given-names></string-name>, 
<string-name name-style="western"><surname>Fischerova</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Harbeck</surname><given-names>N.</given-names></string-name>, 
<string-name name-style="western"><surname>Kuhl</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Lemley</surname><given-names>B.</given-names></string-name>, 
<string-name name-style="western"><surname>Levy-Lahad</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Lambertini</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Ledermann</surname><given-names>J. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Loibl</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Phillips</surname><given-names>K.-A.</given-names></string-name>, and 
<string-name name-style="western"><surname>Paluch-Shimon</surname><given-names>S.</given-names></string-name>, <article-title>Risk Reduction and Screening of Cancer in Hereditary Breast-Ovarian Cancer Syndromes: ESMO Clinical Practice Guideline</article-title>, <source>Annals of Oncology</source>. (<year>2023</year>) <volume>34</volume>, no. 1, <fpage>33</fpage>&#8211;<lpage>47</lpage>, <pub-id pub-id-type="doi">10.1016/j.annonc.2022.10.004</pub-id>.<pub-id pub-id-type="pmid">36307055</pub-id></mixed-citation></ref><ref id="bib-0011"><label>11</label><mixed-citation publication-type="journal" id="cit-0011"><string-name name-style="western"><surname>Daly</surname><given-names>M. B.</given-names></string-name>, 
<string-name name-style="western"><surname>Pal</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Berry</surname><given-names>M. P.</given-names></string-name>, 
<string-name name-style="western"><surname>Buys</surname><given-names>S. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Dickson</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Domchek</surname><given-names>S. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Elkhanany</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Friedman</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Goggins</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Hutton</surname><given-names>M. L.</given-names></string-name>, 
<string-name name-style="western"><surname>CGC</surname></string-name>, 
<string-name name-style="western"><surname>Karlan</surname><given-names>B. Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Khan</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Klein</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Kohlmann</surname><given-names>W.</given-names></string-name>, 
<string-name name-style="western"><surname>CGC</surname></string-name>, <person-group person-group-type="editor"><string-name name-style="western"><surname>Kurian</surname><given-names>A. W.</given-names></string-name></person-group>, <string-name name-style="western"><surname>Laronga</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Litton</surname><given-names>J. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Mak</surname><given-names>J. S.</given-names></string-name>, 
<string-name name-style="western"><surname>LCGC</surname></string-name>, 
<string-name name-style="western"><surname>Menendez</surname><given-names>C. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Merajver</surname><given-names>S. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Norquist</surname><given-names>B. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Offit</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Pederson</surname><given-names>H. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Reiser</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>CGC</surname></string-name>, 
<string-name name-style="western"><surname>Senter-Jamieson</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>CGC</surname></string-name>, 
<string-name name-style="western"><surname>Shannon</surname><given-names>K. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Shatsky</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Visvanathan</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Weitzel</surname><given-names>J. N.</given-names></string-name>, 
<string-name name-style="western"><surname>Wick</surname><given-names>M. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Wisinski</surname><given-names>K. B.</given-names></string-name>, 
<string-name name-style="western"><surname>Yurgelun</surname><given-names>M. B.</given-names></string-name>, 
<string-name name-style="western"><surname>Darlow</surname><given-names>S. D.</given-names></string-name>, and 
<string-name name-style="western"><surname>Dwyer</surname><given-names>M. A.</given-names></string-name>, <article-title>Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology</article-title>, <source>Journal of the National Comprehensive Cancer Network</source>. (<year>2021</year>) <volume>19</volume>, <fpage>77</fpage>&#8211;<lpage>102</lpage>, <pub-id pub-id-type="doi">10.6004/jnccn.2021.0001</pub-id>.<pub-id pub-id-type="pmid">33406487</pub-id></mixed-citation></ref><ref id="bib-0012"><label>12</label><mixed-citation publication-type="journal" id="cit-0012"><string-name name-style="western"><surname>Mancini-DiNardo</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Judkins</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Kidd</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Bernhisel</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Daniels</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Brown</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Meek</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Craft</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Holladay</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Morris</surname><given-names>B.</given-names></string-name>, and 
<string-name name-style="western"><surname>Roa</surname><given-names>B. B.</given-names></string-name>, <article-title>Detection of Large Rearrangements in a Hereditary Pan-Cancer Panel Using Next-Generation Sequencing</article-title>, <source>BMC Medical Genomics</source>. (<year>2019</year>) <volume>12</volume>, no. 1, <pub-id pub-id-type="doi">10.1186/s12920-019-0587-3</pub-id>, 2-s2.0-85073532036.<pub-id pub-id-type="pmcid">PMC6798444</pub-id><pub-id pub-id-type="pmid">31623605</pub-id></mixed-citation></ref><ref id="bib-0013"><label>13</label><mixed-citation publication-type="journal" id="cit-0013"><string-name name-style="western"><surname>Henkel</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Laner</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Locher</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Wohlfrom</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Neitzel</surname><given-names>B.</given-names></string-name>, 
<string-name name-style="western"><surname>Becker</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Neuhann</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Abicht</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Steinke-Lange</surname><given-names>V.</given-names></string-name>, and 
<string-name name-style="western"><surname>Holinski-Feder</surname><given-names>E.</given-names></string-name>, <article-title>Diagnostic Yield and Clinical Relevance of Expanded Germline Genetic Testing for Nearly 7000 Suspected HBOC Patients</article-title>, <source>European Journal of Human Genetics</source>. (<year>2023</year>) <volume>31</volume>, no. 8, <fpage>925</fpage>&#8211;<lpage>930</lpage>, <pub-id pub-id-type="doi">10.1038/s41431-023-01380-2</pub-id>, 37188824.<pub-id pub-id-type="pmid">37188824</pub-id><pub-id pub-id-type="pmcid">PMC10400578</pub-id></mixed-citation></ref><ref id="bib-0014"><label>14</label><mixed-citation publication-type="journal" id="cit-0014"><string-name name-style="western"><surname>Bozsik</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>P&#243;cza</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Papp</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Vaszk&#243;</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Butz</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Pat&#243;cs</surname><given-names>A.</given-names></string-name>, and 
<string-name name-style="western"><surname>Ol&#225;h</surname><given-names>E.</given-names></string-name>, <article-title>Complex Characterization of Germline Large Genomic Rearrangements of the BRCA1 and BRCA2 Genes in High-Risk Breast Cancer Patients&#8212;Novel Variants From a Large National Center</article-title>, <source>International Journal of Molecular Sciences</source>. (<year>2020</year>) <volume>21</volume>, no. 13, <pub-id pub-id-type="doi">10.3390/ijms21134650</pub-id>, 32629901.<pub-id pub-id-type="pmcid">PMC7370166</pub-id><pub-id pub-id-type="pmid">32629901</pub-id></mixed-citation></ref><ref id="bib-0015"><label>15</label><mixed-citation publication-type="journal" id="cit-0015"><string-name name-style="western"><surname>P&#243;cza</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Grolmusz</surname><given-names>V. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Papp</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Butz</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Pat&#243;cs</surname><given-names>A.</given-names></string-name>, and 
<string-name name-style="western"><surname>Bozsik</surname><given-names>A.</given-names></string-name>, <article-title>Germline Structural Variations in Cancer Predisposition Genes</article-title>, <source>Frontiers in Genetics</source>. (<year>2021</year>) <volume>12</volume>, <pub-id pub-id-type="doi">10.3389/fgene.2021.634217</pub-id>, 33936164.<pub-id pub-id-type="pmcid">PMC8081352</pub-id><pub-id pub-id-type="pmid">33936164</pub-id></mixed-citation></ref><ref id="bib-0016"><label>16</label><mixed-citation publication-type="journal" id="cit-0016"><string-name name-style="western"><surname>Riggs</surname><given-names>E. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Andersen</surname><given-names>E. F.</given-names></string-name>, 
<string-name name-style="western"><surname>Cherry</surname><given-names>A. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Kantarci</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Kearney</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Patel</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Raca</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Ritter</surname><given-names>D. I.</given-names></string-name>, 
<string-name name-style="western"><surname>South</surname><given-names>S. T.</given-names></string-name>, 
<string-name name-style="western"><surname>Thorland</surname><given-names>E. C.</given-names></string-name>, 
<string-name name-style="western"><surname>Pineda-Alvarez</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Aradhya</surname><given-names>S.</given-names></string-name>, and 
<string-name name-style="western"><surname>Martin</surname><given-names>C. L.</given-names></string-name>, <article-title>Technical Standards for the Interpretation and Reporting of Constitutional Copy-Number Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen)</article-title>, <source>Genetics in Medicine</source>. (<year>2020</year>) <volume>22</volume>, no. 2, <fpage>245</fpage>&#8211;<lpage>257</lpage>, <pub-id pub-id-type="doi">10.1038/s41436-019-0686-8</pub-id>, 31690835.<pub-id pub-id-type="pmid">31690835</pub-id><pub-id pub-id-type="pmcid">PMC7313390</pub-id></mixed-citation></ref><ref id="bib-0017"><label>17</label><mixed-citation publication-type="journal" id="cit-0017"><string-name name-style="western"><surname>Lepkes</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Kayali</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Bl&#252;mcke</surname><given-names>B.</given-names></string-name>, 
<string-name name-style="western"><surname>Weber</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Suszynska</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Schmidt</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Borde</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Klonowska</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Wappenschmidt</surname><given-names>B.</given-names></string-name>, 
<string-name name-style="western"><surname>Hauke</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Kozlowski</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Schmutzler</surname><given-names>R. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Hahnen</surname><given-names>E.</given-names></string-name>, and 
<string-name name-style="western"><surname>Ernst</surname><given-names>C.</given-names></string-name>, <article-title>Performance of In Silico Prediction Tools for the Detection of Germline Copy Number Variations in Cancer Predisposition Genes in 4208 Female Index Patients With Familial Breast and Ovarian Cancer</article-title>, <source>Cancers</source>. (<year>2021</year>) <volume>13</volume>, no. 1, <pub-id pub-id-type="doi">10.3390/cancers13010118</pub-id>, 33401422.<pub-id pub-id-type="pmcid">PMC7794674</pub-id><pub-id pub-id-type="pmid">33401422</pub-id></mixed-citation></ref><ref id="bib-0018"><label>18</label><mixed-citation publication-type="journal" id="cit-0018"><string-name name-style="western"><surname>Singh</surname><given-names>A. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Olsen</surname><given-names>M. F.</given-names></string-name>, 
<string-name name-style="western"><surname>Lavik</surname><given-names>L. A. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Vold</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Drabl&#248;s</surname><given-names>F.</given-names></string-name>, and 
<string-name name-style="western"><surname>Sjursen</surname><given-names>W.</given-names></string-name>, <article-title>Detecting Copy Number Variation in Next Generation Sequencing Data From Diagnostic Gene Panels</article-title>, <source>BMC Medical Genomics</source>. (<year>2021</year>) <volume>14</volume>, no. 1, <pub-id pub-id-type="doi">10.1186/s12920-021-01059-x</pub-id>.<pub-id pub-id-type="pmcid">PMC8406611</pub-id><pub-id pub-id-type="pmid">34465341</pub-id></mixed-citation></ref><ref id="bib-0019"><label>19</label><mixed-citation publication-type="journal" id="cit-0019"><string-name name-style="western"><surname>Tsaousis</surname><given-names>G. N.</given-names></string-name>, 
<string-name name-style="western"><surname>Papadopoulou</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Apessos</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Agiannitopoulos</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Pepe</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Kampouri</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Diamantopoulos</surname><given-names>N.</given-names></string-name>, 
<string-name name-style="western"><surname>Floros</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Iosifidou</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Katopodi</surname><given-names>O.</given-names></string-name>, 
<string-name name-style="western"><surname>Koumarianou</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Markopoulos</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Papazisis</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Venizelos</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Xanthakis</surname><given-names>I.</given-names></string-name>, 
<string-name name-style="western"><surname>Xepapadakis</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Banu</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Eniu</surname><given-names>D. T.</given-names></string-name>, 
<string-name name-style="western"><surname>Negru</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Stanculeanu</surname><given-names>D. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Ungureanu</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Ozmen</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Tansan</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Tekinel</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Yalcin</surname><given-names>S.</given-names></string-name>, and 
<string-name name-style="western"><surname>Nasioulas</surname><given-names>G.</given-names></string-name>, <article-title>Analysis of Hereditary Cancer Syndromes by Using a Panel of Genes: Novel and Multiple Pathogenic Mutations</article-title>, <source>BMC Cancer</source>. (<year>2019</year>) <volume>19</volume>, no. 1, <pub-id pub-id-type="doi">10.1186/s12885-019-5756-4</pub-id>, 2-s2.0-85066855192, 31159747.<pub-id pub-id-type="pmcid">PMC6547505</pub-id><pub-id pub-id-type="pmid">31159747</pub-id></mixed-citation></ref><ref id="bib-0020"><label>20</label><mixed-citation publication-type="journal" id="cit-0020"><string-name name-style="western"><surname>Agiannitopoulos</surname><given-names>K.</given-names></string-name>, <article-title>Copy Number Variations (CNVs) Account for 10.8% of Pathogenic Variants in Patients Referred for Hereditary Cancer Testing</article-title>, <source>Cancer Genomics &amp; Proteomics</source>. (<year>2023</year>) <volume>20</volume>, no. 5, <fpage>448</fpage>&#8211;<lpage>455</lpage>, <pub-id pub-id-type="doi">10.21873/cgp.20396</pub-id>, 37643779.<pub-id pub-id-type="pmid">37643779</pub-id><pub-id pub-id-type="pmcid">PMC10464942</pub-id></mixed-citation></ref><ref id="bib-0021"><label>21</label><mixed-citation publication-type="journal" id="cit-0021"><string-name name-style="western"><surname>Gordeeva</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Sharova</surname><given-names>E.</given-names></string-name>, and 
<string-name name-style="western"><surname>Arapidi</surname><given-names>G.</given-names></string-name>, <article-title>Progress in Methods for Copy Number Variation Profiling</article-title>, <source>International Journal of Molecular Sciences</source>. (<year>2022</year>) <volume>23</volume>, no. 4, <pub-id pub-id-type="doi">10.3390/ijms23042143</pub-id>.<pub-id pub-id-type="pmcid">PMC8879278</pub-id><pub-id pub-id-type="pmid">35216262</pub-id></mixed-citation></ref><ref id="bib-0022"><label>22</label><mixed-citation publication-type="journal" id="cit-0022"><string-name name-style="western"><surname>Moreno-Cabrera</surname><given-names>J. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Del Valle</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Feliubadal&#243;</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Pineda</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Gonz&#225;lez</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Campos</surname><given-names>O.</given-names></string-name>, 
<string-name name-style="western"><surname>Cuesta</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Brunet</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Serra</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Capell&#224;</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Gel</surname><given-names>B.</given-names></string-name>, and 
<string-name name-style="western"><surname>L&#225;zaro</surname><given-names>C.</given-names></string-name>, <article-title>Screening of CNVs Using NGS Data Improves Mutation Detection Yield and Decreases Costs in Genetic Testing for Hereditary Cancer</article-title>, <source>Journal of Medical Genetics</source>. (<year>2022</year>) <volume>59</volume>, no. 1, <fpage>75</fpage>&#8211;<lpage>78</lpage>, <pub-id pub-id-type="doi">10.1136/jmedgenet-2020-107366</pub-id>, 33219106.<pub-id pub-id-type="pmid">33219106</pub-id></mixed-citation></ref><ref id="bib-0023"><label>23</label><mixed-citation publication-type="journal" id="cit-0023"><string-name name-style="western"><surname>Raca</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Astbury</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Behlmann</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>De Castro</surname><given-names>M. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Hickey</surname><given-names>S. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Karaca</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Lowther</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Riggs</surname><given-names>E. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Seifert</surname><given-names>B. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Thorland</surname><given-names>E. C.</given-names></string-name>, and 
<string-name name-style="western"><surname>Deignan</surname><given-names>J. L.</given-names></string-name>, <article-title>Points to Consider in the Detection of Germline Structural Variants Using Next-Generation Sequencing: A Statement of the American College of Medical Genetics and Genomics (ACMG)</article-title>, <source>Genetics in Medicine</source>. (<year>2023</year>) <volume>25</volume>, no. 2, <elocation-id>100316</elocation-id>, <pub-id pub-id-type="doi">10.1016/j.gim.2022.09.017</pub-id>.<pub-id pub-id-type="pmid">36507974</pub-id></mixed-citation></ref><ref id="bib-0024"><label>24</label><mixed-citation publication-type="journal" id="cit-0024"><string-name name-style="western"><surname>Lerner-Ellis</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Mighton</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Lazaro</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Watkins</surname><given-names>N.</given-names></string-name>, 
<string-name name-style="western"><surname>Di Gioacchino</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Wong</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Chang</surname><given-names>M. C.</given-names></string-name>, and 
<string-name name-style="western"><surname>Charames</surname><given-names>G. S.</given-names></string-name>, <article-title>Multigene Panel Testing for Hereditary Breast and Ovarian Cancer in the Province of Ontario</article-title>, <source>Journal of Cancer Research and Clinical Oncology</source>. (<year>2021</year>) <volume>147</volume>, no. 3, <fpage>871</fpage>&#8211;<lpage>879</lpage>, <pub-id pub-id-type="doi">10.1007/s00432-020-03377-6</pub-id>, 32885271.<pub-id pub-id-type="pmid">32885271</pub-id><pub-id pub-id-type="pmcid">PMC11802097</pub-id></mixed-citation></ref><ref id="bib-0025"><label>25</label><mixed-citation publication-type="journal" id="cit-0025"><string-name name-style="western"><surname>&#214;fverholm</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>T&#246;rngren</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Ros&#233;n</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Arver</surname><given-names>B.</given-names></string-name>, 
<string-name name-style="western"><surname>Einbeigi</surname><given-names>Z.</given-names></string-name>, 
<string-name name-style="western"><surname>Haraldsson</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>St&#229;hlbom</surname><given-names>A. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Kuchinskaya</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Lindblom</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Melin</surname><given-names>B.</given-names></string-name>, 
<string-name name-style="western"><surname>Paulsson-Karlsson</surname><given-names>Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Stenmark-Askmalm</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Tham</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Von Wachenfeldt</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Kvist</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Borg</surname><given-names>&#197;.</given-names></string-name>, and 
<string-name name-style="western"><surname>Ehrencrona</surname><given-names>H.</given-names></string-name>, <article-title>Extended Genetic Analysis and Tumor Characteristics in Over 4600 Women With Suspected Hereditary Breast and Ovarian Cancer</article-title>, <source>BMC Cancer</source>. (<year>2023</year>) <volume>23</volume>, no. 1, <pub-id pub-id-type="doi">10.1186/s12885-023-11229-y</pub-id>, 37563628.<pub-id pub-id-type="pmcid">PMC10413543</pub-id><pub-id pub-id-type="pmid">37563628</pub-id></mixed-citation></ref><ref id="bib-0026"><label>26</label><mixed-citation publication-type="journal" id="cit-0026"><string-name name-style="western"><surname>Toss</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Piombino</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Tenedini</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Bologna</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Gasparini</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Tarantino</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Filieri</surname><given-names>M. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Cottafavi</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Giovanardi</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Madrigali</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Civallero</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Marcheselli</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Marchi</surname><given-names>I.</given-names></string-name>, 
<string-name name-style="western"><surname>Domati</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Venturelli</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Barbieri</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Grandi</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Tagliafico</surname><given-names>E.</given-names></string-name>, and 
<string-name name-style="western"><surname>Cortesi</surname><given-names>L.</given-names></string-name>, <article-title>The Prognostic and Predictive Role of Somatic BRCA Mutations in Ovarian Cancer: Results From a Multicenter Cohort Study</article-title>, <source>Diagnostics</source>. (<year>2021</year>) <volume>11</volume>, no. 3, <pub-id pub-id-type="doi">10.3390/diagnostics11030565</pub-id>.<pub-id pub-id-type="pmcid">PMC8003908</pub-id><pub-id pub-id-type="pmid">33801055</pub-id></mixed-citation></ref><ref id="bib-0027"><label>27</label><mixed-citation publication-type="journal" id="cit-0027"><string-name name-style="western"><surname>Toss</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Tenedini</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Piombino</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Venturelli</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Marchi</surname><given-names>I.</given-names></string-name>, 
<string-name name-style="western"><surname>Gasparini</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Barbieri</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Razzaboni</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Domati</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Caggia</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Grandi</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Combi</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Tazzioli</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Dominici</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Tagliafico</surname><given-names>E.</given-names></string-name>, and 
<string-name name-style="western"><surname>Cortesi</surname><given-names>L.</given-names></string-name>, <article-title>Clinicopathologic Profile of Breast Cancer in Germline ATM and CHEK2 Mutation Carriers</article-title>, <source>Genes</source>. (<year>2021</year>) <volume>12</volume>, no. 5, <pub-id pub-id-type="doi">10.3390/genes12050616</pub-id>.<pub-id pub-id-type="pmcid">PMC8143279</pub-id><pub-id pub-id-type="pmid">33919281</pub-id></mixed-citation></ref><ref id="bib-0028"><label>28</label><mixed-citation publication-type="journal" id="cit-0028"><string-name name-style="western"><surname>Tenedini</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Celestini</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Iapicca</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Marino</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Castellano</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Artuso</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Biagiarelli</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Cortesi</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Toss</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Barbieri</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Roncucci</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Pedroni</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Manfredini</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Luppi</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Trenti</surname><given-names>T.</given-names></string-name>, and 
<string-name name-style="western"><surname>Tagliafico</surname><given-names>E.</given-names></string-name>, <article-title>Automated Capture-Based NGS Workflow: One Thousand Patients Experience in a Clinical Routine Framework</article-title>, <source>Diagnosis</source>. (<year>2022</year>) <volume>9</volume>, no. 1, <fpage>115</fpage>&#8211;<lpage>122</lpage>, <pub-id pub-id-type="doi">10.1515/dx-2021-0051</pub-id>.<pub-id pub-id-type="pmid">34142509</pub-id></mixed-citation></ref><ref id="bib-0029"><label>29</label><mixed-citation publication-type="journal" id="cit-0029"><string-name name-style="western"><surname>Landrum</surname><given-names>M. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Lee</surname><given-names>J. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Riley</surname><given-names>G. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Jang</surname><given-names>W.</given-names></string-name>, 
<string-name name-style="western"><surname>Rubinstein</surname><given-names>W. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Church</surname><given-names>D. M.</given-names></string-name>, and 
<string-name name-style="western"><surname>Maglott</surname><given-names>D. R.</given-names></string-name>, <article-title>Clinvar: Public Archive of Relationships Among Sequence Variation and Human Phenotype</article-title>, <source>Nucleic Acids Research</source>. (<year>2014</year>) <volume>42</volume>, no. D1, <fpage>D980</fpage>&#8211;<lpage>D985</lpage>, <pub-id pub-id-type="doi">10.1093/nar/gkt1113</pub-id>, 2-s2.0-84891809093, 24234437.<pub-id pub-id-type="pmid">24234437</pub-id><pub-id pub-id-type="pmcid">PMC3965032</pub-id></mixed-citation></ref><ref id="bib-0030"><label>30</label><mixed-citation publication-type="journal" id="cit-0030"><string-name name-style="western"><surname>Fokkema</surname><given-names>I. F. A. C.</given-names></string-name>, 
<string-name name-style="western"><surname>Taschner</surname><given-names>P. E. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Schaafsma</surname><given-names>G. C. P.</given-names></string-name>, 
<string-name name-style="western"><surname>Celli</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Laros</surname><given-names>J. F. J.</given-names></string-name>, and 
<string-name name-style="western"><surname>den Dunnen</surname><given-names>J. T.</given-names></string-name>, <article-title>LOVD v.2.0: The Next Generation in Gene Variant Databases</article-title>, <source>Human Mutation</source>. (<year>2011</year>) <volume>32</volume>, <fpage>557</fpage>&#8211;<lpage>563</lpage>, <pub-id pub-id-type="doi">10.1002/humu.21438</pub-id>, 2-s2.0-79954997174.<pub-id pub-id-type="pmid">21520333</pub-id></mixed-citation></ref><ref id="bib-0031"><label>31</label><mixed-citation publication-type="journal" id="cit-0031"><string-name name-style="western"><surname>Kopanos</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Tsiolkas</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Kouris</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Chapple</surname><given-names>C. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Albarca Aguilera</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Meyer</surname><given-names>R.</given-names></string-name>, and 
<string-name name-style="western"><surname>Massouras</surname><given-names>A.</given-names></string-name>, <article-title>VarSome: The Human Genomic Variant Search Engine</article-title>, <source>Bioinformatics</source>. (<year>2019</year>) <volume>35</volume>, no. 11, <fpage>1978</fpage>&#8211;<lpage>1980</lpage>, <pub-id pub-id-type="doi">10.1093/bioinformatics/bty897</pub-id>, 2-s2.0-85063385684.<pub-id pub-id-type="pmid">30376034</pub-id><pub-id pub-id-type="pmcid">PMC6546127</pub-id></mixed-citation></ref><ref id="bib-0032"><label>32</label><mixed-citation publication-type="journal" id="cit-0032"><string-name name-style="western"><surname>Wang</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Li</surname><given-names>M.</given-names></string-name>, and 
<string-name name-style="western"><surname>Hakonarson</surname><given-names>H.</given-names></string-name>, <article-title>ANNOVAR: Functional Annotation of Genetic Variants From High-Throughput Sequencing Data</article-title>, <source>Nucleic Acids Research</source>. (<year>2010</year>) <volume>38</volume>, no. 16, <elocation-id>e164</elocation-id>, <pub-id pub-id-type="doi">10.1093/nar/gkq603</pub-id>, 2-s2.0-77956534324, 20601685.<pub-id pub-id-type="pmid">20601685</pub-id><pub-id pub-id-type="pmcid">PMC2938201</pub-id></mixed-citation></ref><ref id="bib-0033"><label>33</label><mixed-citation publication-type="journal" id="cit-0033"><string-name name-style="western"><surname>McLaren</surname><given-names>W.</given-names></string-name>, 
<string-name name-style="western"><surname>Pritchard</surname><given-names>B.</given-names></string-name>, 
<string-name name-style="western"><surname>Rios</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Flicek</surname><given-names>P.</given-names></string-name>, and 
<string-name name-style="western"><surname>Cunningham</surname><given-names>F.</given-names></string-name>, <article-title>Deriving the Consequences of Genomic Variants With the Ensembl API and SNP Effect Predictor</article-title>, <source>Bioinformatics</source>. (<year>2010</year>) <volume>26</volume>, no. 16, <fpage>2069</fpage>&#8211;<lpage>2070</lpage>, <pub-id pub-id-type="doi">10.1093/bioinformatics/btq330</pub-id>, 2-s2.0-77955405475, 20562413.<pub-id pub-id-type="pmid">20562413</pub-id><pub-id pub-id-type="pmcid">PMC2916720</pub-id></mixed-citation></ref><ref id="bib-0034"><label>34</label><mixed-citation publication-type="journal" id="cit-0034"><string-name name-style="western"><surname>Richards</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Aziz</surname><given-names>N.</given-names></string-name>, 
<string-name name-style="western"><surname>Bale</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Bick</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Das</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Gastier-Foster</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Grody</surname><given-names>W. W.</given-names></string-name>, 
<string-name name-style="western"><surname>Hegde</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Lyon</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Spector</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Voelkerding</surname><given-names>K.</given-names></string-name>, and 
<string-name name-style="western"><surname>Rehm</surname><given-names>H. L.</given-names></string-name>, <article-title>Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>, <source>Genetics in Medicine</source>. (<year>2015</year>) <volume>17</volume>, no. 5, <fpage>405</fpage>&#8211;<lpage>424</lpage>, <pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id>, 2-s2.0-84928209346, 25741868.<pub-id pub-id-type="pmid">25741868</pub-id><pub-id pub-id-type="pmcid">PMC4544753</pub-id></mixed-citation></ref><ref id="bib-0035"><label>35</label><mixed-citation publication-type="journal" id="cit-0035"><string-name name-style="western"><surname>Rehm</surname><given-names>H. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Berg</surname><given-names>J. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Brooks</surname><given-names>L. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Bustamante</surname><given-names>C. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Evans</surname><given-names>J. P.</given-names></string-name>, 
<string-name name-style="western"><surname>Landrum</surname><given-names>M. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Ledbetter</surname><given-names>D. H.</given-names></string-name>, 
<string-name name-style="western"><surname>Maglott</surname><given-names>D. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Martin</surname><given-names>C. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Nussbaum</surname><given-names>R. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Plon</surname><given-names>S. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Ramos</surname><given-names>E. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Sherry</surname><given-names>S. T.</given-names></string-name>, and 
<string-name name-style="western"><surname>Watson</surname><given-names>M. S.</given-names></string-name>, <article-title>ClinGen &#8212; The Clinical Genome Resource</article-title>, <source>New England Journal of Medicine</source>. (<year>2015</year>) <volume>372</volume>, no. 23, <fpage>2235</fpage>&#8211;<lpage>2242</lpage>, <pub-id pub-id-type="doi">10.1056/NEJMsr1406261</pub-id>, 2-s2.0-84930526399.<pub-id pub-id-type="pmid">26014595</pub-id><pub-id pub-id-type="pmcid">PMC4474187</pub-id></mixed-citation></ref><ref id="bib-0036"><label>36</label><mixed-citation publication-type="journal" id="cit-0036"><string-name name-style="western"><surname>Bouras</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Lafaye</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Leone</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Kherraf</surname><given-names>Z.-E.</given-names></string-name>, 
<string-name name-style="western"><surname>Martin-Denavit</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Fert-Ferrer</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Calender</surname><given-names>A.</given-names></string-name>, and 
<string-name name-style="western"><surname>Boutry-Kryza</surname><given-names>N.</given-names></string-name>, <article-title>Identification and Characterization of an Exonic Duplication in PALB2 in a Man With Synchronous Breast and Prostate Cancer</article-title>, <source>International Journal of Molecular Sciences</source>. (<year>2022</year>) <volume>23</volume>, no. 2, <pub-id pub-id-type="doi">10.3390/ijms23020667</pub-id>.<pub-id pub-id-type="pmcid">PMC8775416</pub-id><pub-id pub-id-type="pmid">35054852</pub-id></mixed-citation></ref><ref id="bib-0037"><label>37</label><mixed-citation publication-type="journal" id="cit-0037"><string-name name-style="western"><surname>Sidoti</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Margotta</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Calosci</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Fiorentini</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Bacci</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Gensini</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Papi</surname><given-names>L.</given-names></string-name>, and 
<string-name name-style="western"><surname>Montini</surname><given-names>M.</given-names></string-name>, <article-title>Alu&#8211;Mediated Duplication and Deletion of Exon 11 Are Frequent Mechanisms of PALB2 Inactivation, Predisposing Individuals to Hereditary Breast&#8211;Ovarian Cancer Syndrome</article-title>, <source>Cancers</source>. (<year>2024</year>) <volume>16</volume>, <pub-id pub-id-type="doi">10.3390/cancers16234022</pub-id>.<pub-id pub-id-type="pmcid">PMC11640139</pub-id><pub-id pub-id-type="pmid">39682206</pub-id></mixed-citation></ref><ref id="bib-0038"><label>38</label><mixed-citation publication-type="journal" id="cit-0038"><string-name name-style="western"><surname>Kurian</surname><given-names>A. W.</given-names></string-name>, 
<string-name name-style="western"><surname>Ward</surname><given-names>K. C.</given-names></string-name>, 
<string-name name-style="western"><surname>Abrahamse</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Bondarenko</surname><given-names>I.</given-names></string-name>, 
<string-name name-style="western"><surname>Hamilton</surname><given-names>A. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Deapen</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Morrow</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Berek</surname><given-names>J. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Hofer</surname><given-names>T. P.</given-names></string-name>, and 
<string-name name-style="western"><surname>Katz</surname><given-names>S. J.</given-names></string-name>, <article-title>Time Trends in Receipt of Germline Genetic Testing and Results for Women Diagnosed With Breast Cancer or Ovarian Cancer, 2012-2019</article-title>, <source>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</source>. (<year>2021</year>) <volume>39</volume>, no. 15, <fpage>1631</fpage>&#8211;<lpage>1640</lpage>, <pub-id pub-id-type="doi">10.1200/JCO.20.02785</pub-id>.<pub-id pub-id-type="pmid">33560870</pub-id><pub-id pub-id-type="pmcid">PMC8274804</pub-id></mixed-citation></ref><ref id="bib-0039"><label>39</label><mixed-citation publication-type="journal" id="cit-0039"><string-name name-style="western"><surname>Horton</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Hoang</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Zimmermann</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Young</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Grzybowski</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Durda</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Vuong</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Burks</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Cass</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>LaDuca</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Richardson</surname><given-names>M. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Harrison</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Chao</surname><given-names>E. C.</given-names></string-name>, and 
<string-name name-style="western"><surname>Karam</surname><given-names>R.</given-names></string-name>, <article-title>Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing</article-title>, <source>JAMA Oncology</source>. (<year>2024</year>) <volume>10</volume>, no. 2, <fpage>212</fpage>&#8211;<lpage>219</lpage>, <pub-id pub-id-type="doi">10.1001/jamaoncol.2023.5586</pub-id>, 37924330.<pub-id pub-id-type="pmid">37924330</pub-id><pub-id pub-id-type="pmcid">PMC10625669</pub-id></mixed-citation></ref><ref id="bib-0040"><label>40</label><mixed-citation publication-type="journal" id="cit-0040"><string-name name-style="western"><surname>Ducy</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Sesma-Sanz</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Guitton-Sert</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Lashgari</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Gao</surname><given-names>Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Brahiti</surname><given-names>N.</given-names></string-name>, 
<string-name name-style="western"><surname>Rodrigue</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Margaillan</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Caron</surname><given-names>M.-C.</given-names></string-name>, 
<string-name name-style="western"><surname>C&#244;t&#233;</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Simard</surname><given-names>J.</given-names></string-name>, and 
<string-name name-style="western"><surname>Masson</surname><given-names>J.-Y.</given-names></string-name>, <article-title>The Tumor Suppressor PALB2: Inside Out</article-title>, <source>Trends in Biochemical Sciences</source>. (<year>2019</year>) <volume>44</volume>, no. 3, <fpage>226</fpage>&#8211;<lpage>240</lpage>, <pub-id pub-id-type="doi">10.1016/j.tibs.2018.10.008</pub-id>, 2-s2.0-85059778348, 30638972.<pub-id pub-id-type="pmid">30638972</pub-id></mixed-citation></ref><ref id="bib-0041"><label>41</label><mixed-citation publication-type="journal" id="cit-0041"><string-name name-style="western"><surname>Zhang</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Fan</surname><given-names>Q.</given-names></string-name>, 
<string-name name-style="western"><surname>Ren</surname><given-names>K.</given-names></string-name>, and 
<string-name name-style="western"><surname>Andreassen</surname><given-names>P. R.</given-names></string-name>, <article-title>PALB2 Functionally Connects the Breast Cancer Susceptibility Proteins BRCA1 and BRCA2</article-title>, <source>Molecular Cancer Research</source>. (<year>2009</year>) <volume>7</volume>, no. 7, <fpage>1110</fpage>&#8211;<lpage>1118</lpage>, <pub-id pub-id-type="doi">10.1158/1541-7786.MCR-09-0123</pub-id>, 2-s2.0-67651166786, 19584259.<pub-id pub-id-type="pmid">19584259</pub-id><pub-id pub-id-type="pmcid">PMC4928587</pub-id></mixed-citation></ref><ref id="bib-0042"><label>42</label><mixed-citation publication-type="journal" id="cit-0042"><string-name name-style="western"><surname>Tischkowitz</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Balma&#241;a</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Foulkes</surname><given-names>W. D.</given-names></string-name>, 
<string-name name-style="western"><surname>James</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Ngeow</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Schmutzler</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Voian</surname><given-names>N.</given-names></string-name>, 
<string-name name-style="western"><surname>Wick</surname><given-names>M. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Stewart</surname><given-names>D. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Pal</surname><given-names>T.</given-names></string-name>, and 
<string-name name-style="western"><surname>ACMG Professional Practice and Guidelines Committee</surname></string-name>, <article-title>Management of Individuals With Germline Variants in PALB2: A Clinical Practice Resource of the American College of Medical Genetics and Genomics (ACMG)</article-title>, <source>Genetics in Medicine</source>. (<year>2021</year>) <volume>23</volume>, no. 8, <fpage>1416</fpage>&#8211;<lpage>1423</lpage>, <pub-id pub-id-type="doi">10.1038/s41436-021-01151-8</pub-id>, 33976419.<pub-id pub-id-type="pmid">33976419</pub-id></mixed-citation></ref><ref id="bib-0043"><label>43</label><mixed-citation publication-type="journal" id="cit-0043"><string-name name-style="western"><surname>Zhou</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Wang</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Fu</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Li</surname><given-names>Z.</given-names></string-name>, 
<string-name name-style="western"><surname>Feng</surname><given-names>Q.</given-names></string-name>, 
<string-name name-style="western"><surname>Wu</surname><given-names>W.</given-names></string-name>, 
<string-name name-style="western"><surname>Liu</surname><given-names>Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Wang</surname><given-names>C.</given-names></string-name>, and 
<string-name name-style="western"><surname>Chen</surname><given-names>Y.</given-names></string-name>, <article-title>Spectrum ofPALB2germline Mutations and Characteristics ofPALB2&#8208;related Breast Cancer: Screening of 16,501 Unselected Patients With Breast Cancer and 5890 Controls by Next-Generation Sequencing</article-title>, <source>Cancer</source>. (<year>2020</year>) <volume>126</volume>, no. 14, <fpage>3202</fpage>&#8211;<lpage>3208</lpage>, <pub-id pub-id-type="doi">10.1002/cncr.32905</pub-id>.<pub-id pub-id-type="pmid">32339256</pub-id><pub-id pub-id-type="pmcid">PMC7384117</pub-id></mixed-citation></ref><ref id="bib-0044"><label>44</label><mixed-citation publication-type="journal" id="cit-0044"><string-name name-style="western"><surname>Hu</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Hart</surname><given-names>S. N.</given-names></string-name>, 
<string-name name-style="western"><surname>Gnanaolivu</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Huang</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Lee</surname><given-names>K. Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Na</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Gao</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Lilyquist</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Yadav</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Boddicker</surname><given-names>N. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Samara</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Klebba</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Ambrosone</surname><given-names>C. B.</given-names></string-name>, 
<string-name name-style="western"><surname>Anton-Culver</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Auer</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Bandera</surname><given-names>E. V.</given-names></string-name>, 
<string-name name-style="western"><surname>Bernstein</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Bertrand</surname><given-names>K. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Burnside</surname><given-names>E. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Carter</surname><given-names>B. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Eliassen</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Gapstur</surname><given-names>S. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Gaudet</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Haiman</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Hodge</surname><given-names>J. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Hunter</surname><given-names>D. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Jacobs</surname><given-names>E. J.</given-names></string-name>, 
<string-name name-style="western"><surname>John</surname><given-names>E. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Kooperberg</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Kurian</surname><given-names>A. W.</given-names></string-name>, 
<string-name name-style="western"><surname>Le Marchand</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Lindstroem</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Lindstrom</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Ma</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Neuhausen</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Newcomb</surname><given-names>P. A.</given-names></string-name>, 
<string-name name-style="western"><surname>O&#8217;Brien</surname><given-names>K. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Olson</surname><given-names>J. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Ong</surname><given-names>I. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Pal</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Palmer</surname><given-names>J. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Patel</surname><given-names>A. V.</given-names></string-name>, 
<string-name name-style="western"><surname>Reid</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Rosenberg</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Sandler</surname><given-names>D. P.</given-names></string-name>, 
<string-name name-style="western"><surname>Scott</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Tamimi</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Taylor</surname><given-names>J. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Trentham-Dietz</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Vachon</surname><given-names>C. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Weinberg</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Yao</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Ziogas</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Weitzel</surname><given-names>J. N.</given-names></string-name>, 
<string-name name-style="western"><surname>Goldgar</surname><given-names>D. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Domchek</surname><given-names>S. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Nathanson</surname><given-names>K. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Kraft</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Polley</surname><given-names>E. C.</given-names></string-name>, and 
<string-name name-style="western"><surname>Couch</surname><given-names>F. J.</given-names></string-name>, <article-title>A Population-Based Study of Genes Previously Implicated in Breast Cancer</article-title>, <source>New England Journal of Medicine</source>. (<year>2021</year>) <volume>384</volume>, no. 5, <fpage>440</fpage>&#8211;<lpage>451</lpage>, <pub-id pub-id-type="doi">10.1056/NEJMoa2005936</pub-id>, 33471974.<pub-id pub-id-type="pmid">33471974</pub-id><pub-id pub-id-type="pmcid">PMC8127622</pub-id></mixed-citation></ref><ref id="bib-0045"><label>45</label><mixed-citation publication-type="journal" id="cit-0045"><string-name name-style="western"><surname>Yadav</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Boddicker</surname><given-names>N. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Na</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Polley</surname><given-names>E. C.</given-names></string-name>, 
<string-name name-style="western"><surname>Hu</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Hart</surname><given-names>S. N.</given-names></string-name>, 
<string-name name-style="western"><surname>Gnanaolivu</surname><given-names>R. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Larson</surname><given-names>N.</given-names></string-name>, 
<string-name name-style="western"><surname>Holtegaard</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Huang</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Dunn</surname><given-names>C. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Teras</surname><given-names>L. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Patel</surname><given-names>A. V.</given-names></string-name>, 
<string-name name-style="western"><surname>Lacey</surname><given-names>J. V.</given-names></string-name>, 
<string-name name-style="western"><surname>Neuhausen</surname><given-names>S. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Martinez</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Haiman</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Chen</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Ruddy</surname><given-names>K. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Olson</surname><given-names>J. E.</given-names></string-name>, 
<string-name name-style="western"><surname>John</surname><given-names>E. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Kurian</surname><given-names>A. W.</given-names></string-name>, 
<string-name name-style="western"><surname>Sandler</surname><given-names>D. P.</given-names></string-name>, 
<string-name name-style="western"><surname>O&#8217;Brien</surname><given-names>K. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Taylor</surname><given-names>J. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Weinberg</surname><given-names>C. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Anton-Culver</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Ziogas</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Zirpoli</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Goldgar</surname><given-names>D. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Palmer</surname><given-names>J. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Domchek</surname><given-names>S. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Weitzel</surname><given-names>J. N.</given-names></string-name>, 
<string-name name-style="western"><surname>Nathanson</surname><given-names>K. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Kraft</surname><given-names>P.</given-names></string-name>, and 
<string-name name-style="western"><surname>Couch</surname><given-names>F. J.</given-names></string-name>, <article-title>Contralateral Breast Cancer Risk Among Carriers of Germline Pathogenic Variants in ATM, BRCA1, BRCA2, CHEK2, and PALB2</article-title>, <source>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</source>. (<year>2023</year>) <volume>41</volume>, no. 9, <fpage>1703</fpage>&#8211;<lpage>1713</lpage>, <pub-id pub-id-type="doi">10.1200/JCO.22.01239</pub-id>, 36623243.<pub-id pub-id-type="pmid">36623243</pub-id><pub-id pub-id-type="pmcid">PMC10022863</pub-id></mixed-citation></ref><ref id="bib-0046"><label>46</label><mixed-citation publication-type="journal" id="cit-0046"><string-name name-style="western"><surname>Breast Cancer Association Consortium</surname></string-name>, <article-title>Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility</article-title>, <source>Genes Oncologia</source>. (<year>2022</year>) <volume>8</volume>, no. 3, <elocation-id>e216744</elocation-id>, <pub-id pub-id-type="doi">10.1001/jamaoncol.2021.6744</pub-id>.<pub-id pub-id-type="pmcid">PMC8796069</pub-id><pub-id pub-id-type="pmid">35084436</pub-id></mixed-citation></ref><ref id="bib-0047"><label>47</label><mixed-citation publication-type="journal" id="cit-0047"><string-name name-style="western"><surname>Yang</surname><given-names>X.</given-names></string-name>, 
<string-name name-style="western"><surname>Leslie</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Doroszuk</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Schneider</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Allen</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Decker</surname><given-names>B.</given-names></string-name>, 
<string-name name-style="western"><surname>Dunning</surname><given-names>A. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Redman</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Scarth</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Plaskocinska</surname><given-names>I.</given-names></string-name>, 
<string-name name-style="western"><surname>Luccarini</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Shah</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Pooley</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Dorling</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Lee</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Adank</surname><given-names>M. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Adlard</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Aittom&#228;ki</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Andrulis</surname><given-names>I. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Ang</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Barwell</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Bernstein</surname><given-names>J. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Bobolis</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Borg</surname><given-names>&#197;.</given-names></string-name>, 
<string-name name-style="western"><surname>Blomqvist</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Claes</surname><given-names>K. B. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Concannon</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Cuggia</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Culver</surname><given-names>J. O.</given-names></string-name>, 
<string-name name-style="western"><surname>Damiola</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>De Pauw</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Diez</surname><given-names>O.</given-names></string-name>, 
<string-name name-style="western"><surname>Dolinsky</surname><given-names>J. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Domchek</surname><given-names>S. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Engel</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Evans</surname><given-names>D. G.</given-names></string-name>, 
<string-name name-style="western"><surname>Fostira</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Garber</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Golmard</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Goode</surname><given-names>E. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Gruber</surname><given-names>S. B.</given-names></string-name>, 
<string-name name-style="western"><surname>Hahnen</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Hake</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Heikkinen</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Hurley</surname><given-names>J. E.</given-names></string-name>, 
<string-name name-style="western"><surname>Janavicius</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Kleibl</surname><given-names>Z.</given-names></string-name>, 
<string-name name-style="western"><surname>Kleiblova</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Konstantopoulou</surname><given-names>I.</given-names></string-name>, 
<string-name name-style="western"><surname>Kvist</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Laduca</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Lee</surname><given-names>A. S. G.</given-names></string-name>, 
<string-name name-style="western"><surname>Lesueur</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Maher</surname><given-names>E. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Mannermaa</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Manoukian</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>McFarland</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>McKinnon</surname><given-names>W.</given-names></string-name>, 
<string-name name-style="western"><surname>Meindl</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Metcalfe</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Mohd Taib</surname><given-names>N. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Moilanen</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Nathanson</surname><given-names>K. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Neuhausen</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Ng</surname><given-names>P. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Nguyen-Dumont</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Nielsen</surname><given-names>S. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Obermair</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Offit</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Olopade</surname><given-names>O. I.</given-names></string-name>, 
<string-name name-style="western"><surname>Ottini</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Penkert</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Pylk&#228;s</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Radice</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Ramus</surname><given-names>S. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Rudaitis</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Side</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Silva-Smith</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Silvestri</surname><given-names>V.</given-names></string-name>, 
<string-name name-style="western"><surname>Skytte</surname><given-names>A.-B.</given-names></string-name>, 
<string-name name-style="western"><surname>Slavin</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Soukupova</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Tondini</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Trainer</surname><given-names>A. H.</given-names></string-name>, 
<string-name name-style="western"><surname>Unzeitig</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Usha</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Van Overeem</surname><given-names>H. T.</given-names></string-name>, 
<string-name name-style="western"><surname>Whitworth</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Wood</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Yip</surname><given-names>C. H.</given-names></string-name>, 
<string-name name-style="western"><surname>Yoon</surname><given-names>S.-Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Yussuf</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Zogopoulos</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Goldgar</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Hopper</surname><given-names>J. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Chenevix-Trench</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Pharoah</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>George</surname><given-names>S. H. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Balma&#241;a</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Houdayer</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>James</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>El-Haffaf</surname><given-names>Z.</given-names></string-name>, 
<string-name name-style="western"><surname>Ehrencrona</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Janatova</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Peterlongo</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Nevanlinna</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Schmutzler</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Teo</surname><given-names>S.-H.</given-names></string-name>, 
<string-name name-style="western"><surname>Robson</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Pal</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Couch</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Weitzel</surname><given-names>J. N.</given-names></string-name>, 
<string-name name-style="western"><surname>Elliott</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Southey</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Winqvist</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Easton</surname><given-names>D. F.</given-names></string-name>, 
<string-name name-style="western"><surname>Foulkes</surname><given-names>W. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Antoniou</surname><given-names>A. C.</given-names></string-name>, and 
<string-name name-style="western"><surname>Tischkowitz</surname><given-names>M.</given-names></string-name>, <article-title>Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families</article-title>, <source>Journal of Clinical Oncology</source>. (<year>2020</year>) <volume>38</volume>, no. 7, <fpage>674</fpage>&#8211;<lpage>685</lpage>, <pub-id pub-id-type="doi">10.1200/JCO.19.01907</pub-id>.<pub-id pub-id-type="pmid">31841383</pub-id><pub-id pub-id-type="pmcid">PMC7049229</pub-id></mixed-citation></ref><ref id="bib-0048"><label>48</label><mixed-citation publication-type="journal" id="cit-0048"><string-name name-style="western"><surname>Song</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Dicks</surname><given-names>E. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Tyrer</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Intermaggio</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Chenevix-Trench</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Bowtell</surname><given-names>D. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Traficante</surname><given-names>N.</given-names></string-name>, 
<string-name name-style="western"><surname>Group A</surname></string-name>, 
<string-name name-style="western"><surname>Brenton</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Goranova</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Hosking</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Piskorz</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>van Oudenhove</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Doherty</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Harris</surname><given-names>H. R.</given-names></string-name>, 
<string-name name-style="western"><surname>Rossing</surname><given-names>M. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Duerst</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Dork</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Bogdanova</surname><given-names>N. V.</given-names></string-name>, 
<string-name name-style="western"><surname>Modugno</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Moysich</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Odunsi</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Ness</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Karlan</surname><given-names>B. Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Lester</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Jensen</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Kr&#252;ger Kjaer</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>H&#248;gdall</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Campbell</surname><given-names>I. G.</given-names></string-name>, 
<string-name name-style="western"><surname>L&#225;zaro</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Pujara</surname><given-names>M. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Cunningham</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Vierkant</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Winham</surname><given-names>S. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Hildebrandt</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Huff</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Li</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Wu</surname><given-names>X.</given-names></string-name>, 
<string-name name-style="western"><surname>Yu</surname><given-names>Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Permuth</surname><given-names>J. B.</given-names></string-name>, 
<string-name name-style="western"><surname>Levine</surname><given-names>D. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Schildkraut</surname><given-names>J. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Riggan</surname><given-names>M. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Berchuck</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Webb</surname><given-names>P. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Group OS</surname></string-name>, 
<string-name name-style="western"><surname>Cybulski</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Gronwald</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Jakubowska</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Lubinski</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Alsop</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Harrington</surname><given-names>P.</given-names></string-name>, 
<string-name name-style="western"><surname>Chan</surname><given-names>I.</given-names></string-name>, 
<string-name name-style="western"><surname>Menon</surname><given-names>U.</given-names></string-name>, 
<string-name name-style="western"><surname>Pearce</surname><given-names>C. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Wu</surname><given-names>A. H.</given-names></string-name>, 
<string-name name-style="western"><surname>de Fazio</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Kennedy</surname><given-names>C. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Goode</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Ramus</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Gayther</surname><given-names>S.</given-names></string-name>, and 
<string-name name-style="western"><surname>Pharoah</surname><given-names>P.</given-names></string-name>, <article-title>Population-Based Targeted Sequencing of 54 Candidate Genes Identifies PALB2 as a Susceptibility Gene for High-Grade Serous Ovarian Cancer</article-title>, <source>Journal of Medical Genetics</source>. (<year>2021</year>) <volume>58</volume>, no. 5, <fpage>305</fpage>&#8211;<lpage>313</lpage>, <pub-id pub-id-type="doi">10.1136/jmedgenet-2019-106739</pub-id>, 32546565.<pub-id pub-id-type="pmid">32546565</pub-id><pub-id pub-id-type="pmcid">PMC8086250</pub-id></mixed-citation></ref><ref id="bib-0049"><label>49</label><mixed-citation publication-type="journal" id="cit-0049"><string-name name-style="western"><surname>Toss</surname><given-names>A.</given-names></string-name>, 
<string-name name-style="western"><surname>Ponzoni</surname><given-names>O.</given-names></string-name>, 
<string-name name-style="western"><surname>Ricc&#242;</surname><given-names>B.</given-names></string-name>, 
<string-name name-style="western"><surname>Piombino</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Moscetti</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Combi</surname><given-names>F.</given-names></string-name>, 
<string-name name-style="western"><surname>Palma</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Papi</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Tenedini</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Tazzioli</surname><given-names>G.</given-names></string-name>, 
<string-name name-style="western"><surname>Dominici</surname><given-names>M.</given-names></string-name>, and 
<string-name name-style="western"><surname>Cortesi</surname><given-names>L.</given-names></string-name>, <article-title>Management ofPALB2&#8208;associated Breast Cancer: A Literature Review and Case Report</article-title>, <source>Clinical Case Reports</source>. (<year>2023</year>) <volume>11</volume>, no. 8, <elocation-id>e7747</elocation-id>, <pub-id pub-id-type="doi">10.1002/ccr3.7747</pub-id>.<pub-id pub-id-type="pmid">37621724</pub-id><pub-id pub-id-type="pmcid">PMC10444947</pub-id></mixed-citation></ref><ref id="bib-0050"><label>50</label><mixed-citation publication-type="journal" id="cit-0050"><string-name name-style="western"><surname>Schrader</surname><given-names>K. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Stratton</surname><given-names>K. L.</given-names></string-name>, 
<string-name name-style="western"><surname>Murali</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Laitman</surname><given-names>Y.</given-names></string-name>, 
<string-name name-style="western"><surname>Cavallone</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Offit</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Wen</surname><given-names>Y. H.</given-names></string-name>, 
<string-name name-style="western"><surname>Thomas</surname><given-names>T.</given-names></string-name>, 
<string-name name-style="western"><surname>Shah</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Rau-Murthy</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Manschreck</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Salo-Mullen</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Otegbeye</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Corines</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Zhang</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Norton</surname><given-names>L.</given-names></string-name>, 
<string-name name-style="western"><surname>Hudis</surname><given-names>C.</given-names></string-name>, 
<string-name name-style="western"><surname>Klein</surname><given-names>R. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Kauff</surname><given-names>N. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Robson</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Stadler</surname><given-names>Z. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Haber</surname><given-names>D. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Lipkin</surname><given-names>S. M.</given-names></string-name>, 
<string-name name-style="western"><surname>Friedman</surname><given-names>E.</given-names></string-name>, 
<string-name name-style="western"><surname>Foulkes</surname><given-names>W. D.</given-names></string-name>, 
<string-name name-style="western"><surname>Altshuler</surname><given-names>D.</given-names></string-name>, 
<string-name name-style="western"><surname>Vijai</surname><given-names>J.</given-names></string-name>, and 
<string-name name-style="western"><surname>Offit</surname><given-names>K.</given-names></string-name>, <article-title>Genome Sequencing of Multiple Primary Tumors Reveals a NovelPALB2Variant</article-title>, <source>Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology</source>. (<year>2016</year>) <volume>34</volume>, no. 8, <fpage>e61</fpage>&#8211;<lpage>e67</lpage>, <pub-id pub-id-type="doi">10.1200/JCO.2013.50.0272</pub-id>, 2-s2.0-84961129917.<pub-id pub-id-type="pmid">24982446</pub-id></mixed-citation></ref><ref id="bib-0051"><label>51</label><mixed-citation publication-type="journal" id="cit-0051"><string-name name-style="western"><surname>Cilento</surname><given-names>M. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Poplawski</surname><given-names>N. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Paramasivam</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Thomas</surname><given-names>D. M.</given-names></string-name>, and 
<string-name name-style="western"><surname>Kichenadasse</surname><given-names>G.</given-names></string-name>, <article-title>Germline PALB2 Variants and PARP Inhibitors in Endometrial Cancer</article-title>, <source>Journal of the National Comprehensive Cancer Network</source>. (<year>2021</year>) <volume>19</volume>, no. 11, <fpage>1212</fpage>&#8211;<lpage>1217</lpage>, <pub-id pub-id-type="doi">10.6004/jnccn.2021.7067</pub-id>.<pub-id pub-id-type="pmid">34781271</pub-id></mixed-citation></ref><ref id="bib-0052"><label>52</label><mixed-citation publication-type="journal" id="cit-0052"><string-name name-style="western"><surname>Park</surname><given-names>J. S.</given-names></string-name>, 
<string-name name-style="western"><surname>Shin</surname><given-names>S.</given-names></string-name>, 
<string-name name-style="western"><surname>Lee</surname><given-names>Y. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Lee</surname><given-names>S.-T.</given-names></string-name>, 
<string-name name-style="western"><surname>Nam</surname><given-names>E. J.</given-names></string-name>, 
<string-name name-style="western"><surname>Han</surname><given-names>J. W.</given-names></string-name>, 
<string-name name-style="western"><surname>Lee</surname><given-names>S. H.</given-names></string-name>, 
<string-name name-style="western"><surname>Kim</surname><given-names>T. I.</given-names></string-name>, and 
<string-name name-style="western"><surname>Park</surname><given-names>H. S.</given-names></string-name>, <article-title>Implication and Influence of Multigene Panel Testing With Genetic Counseling in Korean Patients With BRCA1/2 Mutation-Negative Breast Cancer</article-title>, <source>Cancer Research and Treatment</source>. (<year>2022</year>) <volume>54</volume>, no. 4, <fpage>1099</fpage>&#8211;<lpage>1110</lpage>, <pub-id pub-id-type="doi">10.4143/crt.2021.978</pub-id>, 34793666.<pub-id pub-id-type="pmid">34793666</pub-id><pub-id pub-id-type="pmcid">PMC9582472</pub-id></mixed-citation></ref><ref id="bib-0053"><label>53</label><mixed-citation publication-type="journal" id="cit-0053"><string-name name-style="western"><surname>Sen</surname><given-names>S. K.</given-names></string-name>, 
<string-name name-style="western"><surname>Han</surname><given-names>K.</given-names></string-name>, 
<string-name name-style="western"><surname>Wang</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Lee</surname><given-names>J.</given-names></string-name>, 
<string-name name-style="western"><surname>Wang</surname><given-names>H.</given-names></string-name>, 
<string-name name-style="western"><surname>Callinan</surname><given-names>P. A.</given-names></string-name>, 
<string-name name-style="western"><surname>Dyer</surname><given-names>M.</given-names></string-name>, 
<string-name name-style="western"><surname>Cordaux</surname><given-names>R.</given-names></string-name>, 
<string-name name-style="western"><surname>Liang</surname><given-names>P.</given-names></string-name>, and 
<string-name name-style="western"><surname>Batzer</surname><given-names>M. A.</given-names></string-name>, <article-title>Human Genomic Deletions Mediated by Recombination Between Alu Elements</article-title>, <source>American Journal of Human Genetics</source>. (<year>2006</year>) <volume>79</volume>, no. 1, <fpage>41</fpage>&#8211;<lpage>53</lpage>, <pub-id pub-id-type="doi">10.1086/504600</pub-id>, 2-s2.0-33745244299.<pub-id pub-id-type="pmid">16773564</pub-id><pub-id pub-id-type="pmcid">PMC1474114</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>